1

PMID
26810140
26740371
26718665
26390721
26327630
26322249
26314268
26286115
26238810
26134012
26075048
25942075
25882700
25708216
25698612
25655380
25621808
25615933
25511404
25486581
25459175
25445640
25434302
25408851
25387866
25373730
25316679
25300870
25297761
25284463
25272241
25262825
25255163
25178518
25119132
25072307
25064747
25064745
25017763
25014772
24993587
24986801
24972767
24961645
24951467
24923299
24907626
24837891
24815062
24798307
24781016
24769317
24747334
24725691
24725690
24704575
24691222
24662418
24649942

Digital ObjArticle TitlAbstract Language Journal: TiJournal: AJournal: NJournal: YJournal: Journal: M
http://www.sci-hub.io/10.1016/j.transci.2016.01.010
RetrospectiCompared ENG
to
TransfusionTransfus A 1010956532016
Jan
http://www.sci-hub.io/10.1016/j.bbmt.2015.12.013
A Pilot Stu Mycophenolate
ENG mofetilBiology
(MMF),ofanBiol
ester
Blood
prodrug
9600628
of mycophenolic
2015
acid
Dec (MPA), is used increasin
http://www.sci-hub.io/10.1016/j.bbmt.2015.12.008
Success ofThe
an International
American
engSociety
Learning
Biology
for Blood
Health
of and
Biol
Care
Marrow
Blood
System
9600628
Transplantation
in Hematopoietic
2016 (ASBMT)
Cell
MarTransplantation:
Clinical Case Forum
The Ame
(CC
[AutologousTo analyze rus
Terapevtiche
Ter Arkh 2984818R 2015
http://www.sci-hub.io/10.1016/j.bbmt.2015.08.022
In Vivo T CThe inclusieng
Biology of Biol Blood 9600628 2015
Dec
http://www.sci-hub.io/10.1186/s40164-015-0015-0
Allogeneic The outcomes
eng of adultExperiment
acute lymphoblastic
Exp Hemato
leukemia
101590676
(ALL)
2015patients with chemotherapy or auto
http://www.sci-hub.io/10.1007/s00292-015-0087-y
[Acute leukThe prognos
ger
Der Pathol Pathologe 8006541 2015
Sep
http://www.sci-hub.io/10.1038/leu.2015.230
Improved su
This nationeng
Leukemia Leukemia 8704895 2016
Feb
http://www.sci-hub.io/10.1016/j.bbmt.2015.07.029
cord bloodBiology
(DCB) of
grafts
a rapidly
9600628
available
High DiseaDouble-uniteng
Biolare
Blood
2015stem cell
Novsource for adults with high
http://www.sci-hub.io/10.3760/cma.j.issn.0253-2727.2015.06.007
[AutologousTo evaluatechi
Zhonghua xZhonghua X
8212398 2015
Jun
http://www.sci-hub.io/10.4084/MJHID.2015.041
Good Outcom
Acute lymph
eng
MediterraneMediterr J 1015305122015
http://www.sci-hub.io/10.3109/08880018.2015.1020178
Age at Bir We studiedeng
Pediatric Pediatr He 8700164 2015
May
http://www.sci-hub.io/10.1038/leu.2015.98
Comparison
Outcomes eng
af
Leukemia Leukemia 8704895 2015
Sep
http://www.sci-hub.io/10.1016/j.bbmt.2015.02.013
Phenotypica
Chronic graeng
Biology of Biol Blood 9600628 2015
Jun
http://www.sci-hub.io/10.1016/j.bbmt.2015.02.009
HaploidentiThe role ofeng
Biology of Biol Blood 9600628 2015
Jun
http://www.sci-hub.io/10.1007/s12185-015-1755-7
of third allogeneic
stem
9111627
cell transplantation
Third allog We analyzed
engthe results
Internation
Int J Hemat
2015
Apr(SCT3) using single-unit u
http://www.sci-hub.io/10.1038/bmt.2014.302
Comparison
We compared
eng
Bone marroBone Marro8702459 2015
Apr
http://www.sci-hub.io/10.1002/ajh.23955
Mycophenola
We retrospe
eng
American j Am J Hema7610369 2015
May
[Increased To investig chi
Zhonghua n
Zhonghua N
16210490R2014
Sep
http://www.sci-hub.io/10.1038/bmt.2014.274
Presence of
Relapse of eng
Bone marroBone Marro8702459 2015
Mar
http://www.sci-hub.io/10.1016/j.hoc.2014.08.008
Allogeneic This revieweng
Hematology/
Hematol On8709473 2014
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2014.09.027
Gamma delta
After hemateng
Biology of Biol Blood 9600628 2015
Jan
http://www.sci-hub.io/10.1038/leu.2014.336
A survey onThe use of eng
Leukemia Leukemia 8704895 2015
May
http://www.sci-hub.io/10.4084/MJHID.2014.065
Role of all Adult acuteeng
MediterraneMediterr J 1015305122014
http://www.sci-hub.io/10.1002/cncr.29141
Phase 1/2 sAllogeneic eng
Cancer
Cancer
0374236 2015
Mar
http://www.sci-hub.io/10.1038/srep06942
Reduced-tox
Conventiona
eng
Scientific r Sci Rep 1015632882014
http://www.sci-hub.io/10.1182/blood-2014-07-587477
7603509 2014
Single-ageHigh-dose,eng
Blood
Blood
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2014.09.012
Patients wiDespite theeng
Biology of Biol Blood 9600628 2015
Jan
[Treatment of adult Phjpn
[Rinsho ke Rinsho Ket2984782R 2014
Oct
http://www.sci-hub.io/10.1111/bjh.13148
Incidence aCataract waeng
British jou Br J Haema0372544 2015
Feb
http://www.sci-hub.io/10.1111/bjh.13136
Results of Double-uniteng
cord bloodBritish
(CB) grafts
jou Brmay
J Haema
improve
0372544
engraftment
2015 and relapse
Feb
risk in adults with hae
http://www.sci-hub.io/10.1002/pbc.25245
Hematopoiet
Hematopoiet
eng
Pediatric b Pediatr Bl 1011866242015
Jan
http://www.sci-hub.io/10.1016/j.bbmt.2014.09.013
Favorable oConditionineng
Biology of Biol Blood 9600628 2015
Jan
http://www.sci-hub.io/10.1007/s00277-014-2195-9
MyeloablatiPhiladelphieng
Annals of Ann Hemat9107334 2015
Feb
http://www.sci-hub.io/10.1097/TP.0000000000000385
Changes inAllogeneic eng
TransplantaTransplanta0132144 2014
Oct
http://www.sci-hub.io/10.1089/scd.2014.0123
Comparison
Currently, eng
Stem cells Stem Cells1011971072014
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2014.07.021
Hospital le Several stueng
Biology of Biol Blood 9600628 2014
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2014.07.020
CalcineurinCalcineurineng
Biology of Biol Blood 9600628 2014
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2014.07.005
Central nerCentral nereng
Biology of Biol Blood 9600628 2014
Nov
http://www.sci-hub.io/10.1038/bcj.2014.48
Different molecular le eng
Blood cance
Blood Canc1015684692014
http://www.sci-hub.io/10.1179/1607845414Y.0000000175
Allogeneic Myeloablatieng
Hematology
Hematolog9708388 2015
Mar
http://www.sci-hub.io/10.1038/bmt.2014.72
Risk factor We performe
eng
Bone marroBone Marro8702459 2014
Jul
http://www.sci-hub.io/10.3324/haematol.2014.109280
Engraftment
Umbilical ceng
Haematolog
Haematolog
0417435 2014
Sep
http://www.sci-hub.io/10.1111/bjh.12970
Impact of mThe status eng
British jou Br J Haema0372544 2014
Sep
http://www.sci-hub.io/10.3324/haematol.2014.108563
0417435 2014
Results froWe prospect
eng
Haematolog
Haematolog
Sep
http://www.sci-hub.io/10.1182/blood-2014-03-564401
HLA-haploid
Posttranspleng
Blood
Blood
7603509 2014
Jul
http://www.sci-hub.io/10.1016/j.bbmt.2014.05.026
Comparison
Little data eng
Biology of Biol Blood 9600628 2014
Oct
http://www.sci-hub.io/10.1016/j.ijrobp.2014.02.032
Similar sur Hematopoiet
eng
Internation Int J Radia 7603616 2014
Jun
http://www.sci-hub.io/10.1111/petr.12276
of CRT
and ITTra
chemotherapy,
9802574 2014
in addition
to conditioning including TB
Efficacy of We evaluated
engthe efficacy
Pediatric
t Pediatr
Aug
http://www.sci-hub.io/10.1097/TP.0000000000000102
Who is the Female dono
eng
TransplantaTransplanta0132144 2014
Sep
http://www.sci-hub.io/10.1038/leu.2014.145
Sensitivity After allog eng
Leukemia Leukemia 8704895 2014
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2014.04.018
Minimal residual
(MRD)
is an important
Immunoglobu
eng disease
Biology
of quantification
Biol Blood 9600628
2014 predictor
Sep of outcome after treatm
http://www.sci-hub.io/10.1016/j.bbmt.2014.04.011
Superior suWe wantedeng
to compare
Biology
the efficacy
of BiolofBlood
haploidentical
9600628 hematopoietic
2014
Sep
stem cell transplantation (H
http://www.sci-hub.io/10.1016/j.ijrobp.2014.01.036
ExtramedullApproximate
eng
Internation Int J Radia 7603616 2014
May
http://www.sci-hub.io/10.1016/j.ijrobp.2014.01.056
Survival anTo evaluateeng
Internation Int J Radia 7603616 2014
May
http://www.sci-hub.io/10.1016/j.bbmt.2014.03.030
ExtramedullExtramedulleng
Biology of Biol Blood 9600628 2014
Jul
http://www.sci-hub.io/10.1016/j.bbmt.2014.03.028
Factors preThe presenc
eng
Biology of Biol Blood 9600628 2014
Jul
http://www.sci-hub.io/10.1038/bmt.2014.54
PBSC vs BM
Few studieseng
Bone marroBone Marro8702459 2014
Jun
http://www.sci-hub.io/10.1111/ejh.12317
Long-term fThe purpose
eng
European jEur J Haem8703985 2014
Aug
321122634.xlsx

Journal: Journal: I Journal: MCitation

Internet
Internet
22
3
564-70
Internet
87
7
15-25
Print
21
12
2173-9
Internet
4
20
Print
36
5
503-17; quiInternet
30
2
310-7
Internet
21
11
1985-93 Internet
36
6
480-4
Print
7
1
e2015041 Print
32
4
273-83
Internet
29
9
1891-900 Internet
21
6
1020-8
Internet
21
6
1110-6
Internet
101
4
392-7
Internet
50
4
493-8
Internet
90
5
392-9
Internet
53
9
710-4
Print
50
3
348-53
Internet
28
6
995-1009 Internet
21
1
130-6
Internet
29
5
1069-75 Internet
6
1
e2014065 Print
121
6
863-71
Internet
4
6942
Internet
124
25
3817-27 Internet
21
1
184-9
Internet
55
10
1962-71 Print
168
4
518-25
Internet
168
3
405-12
Internet
62
1
148-52
Internet
21
1
190-5
Internet
94
2
289-96
Internet
98
7
706-12
Internet
23
21
2535-52 Internet
20
11
1819-27 Internet
20
11
1828-34 Internet
20
11
1767-71 Internet
4
e225
Print
20
2
61-71
Internet
49
7
887-94
Internet
99
9
1509-15 Internet
166
5
749-57
Internet
99
9
1486-91 Internet
124
4
638-44
Internet
20
10
1522-9
Internet
89
2
360-9
Internet
18
5
518-23
Internet
98
5
569-77
Internet
28
11
2235-40 Internet
20
9
1307-13 Internet
20
9
1314-21 Internet
89
1
75-81
Internet
89
1
67-74
Internet
20
7
1040-7
Internet
20
7
1033-9
Internet
49
6
773-9
Internet
93
2
137-42
Internet

First AuthoAll AuthorsAffiliation Related CiRelated CiRelated ArRelated Ar

Emre TekgTekgndz,Hematologyclick here click here click here click here
Randy M WWindreich,Division of click here click here click here click here
Pere BarbaBarba, P; BDepartmentclick here click here click here click here
E N ParoviParovichnikova, EN; Kclick here click here click here click here
Doris M PoPonce, DM;Adult Boneclick here click here click here click here
Masahiro Imamura, M
Departmentclick here click here click here click here
E EigendorfEigendorff,Abteilung Hclick here click here click here click here
A G DinmoDinmohamed
Departmentclick here click here click here click here
Doris M PoPonce, DM;Adult Boneclick here click here click here click here
State Key Laboratory
Experimental
Hematology,
Institute of
Tingyu Wa Wang, T; Zo
click here of
click
here click here
click here
Matteo Pa Parma, M; H
Vaematolog
click here click here click here click here
Fernand FrFreycon, F;Childhood click here click here click here click here
A Ruggeri Ruggeri, A;Hpital Saiclick here click here click here click here
Binsheng Wang, B; Hu
Bone Marrow
click here click here click here click here
Huan ChenChen, H; LPeking Univclick here click here click here click here
Takaaki K Konuma, T;Departmentclick here click here click here click here
G S HobbsHobbs, GS;1] Adult Boclick here click here click here click here
Nada HamHamad, N; Allogeneic
S
click here click here click here click here
Yao Chen Chen, Y; XuInstitute o click here click here click here click here
Y Kong
Kong, Y; XuPeking Univclick here click here click here click here
David I MaMarks, DI; Adult BMT click
U here click here click here click here
Ross Perk Perko, R; Departmentclick here click here click here click here
click here click here click here click here
S Piemont Piemontese,
1] Hematolo
Federico L Lussana, FHematologyclick here click here click here click here
Avichai Sh Shimoni, A;Division o click here click here click here click here
Koichi HiraHirabayashiDepartmentclick here click here click here click here
ChristopheKanakry, CG
Sidney Kimclick here click here click here click here
Daniel N EEgan, DN; Division of click here click here click here click here
Kiyotoshi I Imai, K
click here click here click here click here
Meryl HorwiHorwitz, M;Departmentclick here click here click here click here
Juliet N BaBarker, JN;Adult Boneclick here click here click here click here
Hiroaki GotGoto, H; KaDivision o click here click here click here click here
Ji Won LeeLee, JW; Ka
Departmentclick here click here click here click here
Takaaki K Konuma, T;Departmentclick here click here click here click here
Camillo AlmAlmici, C; 1 Laboratorclick here click here click here click here
S Fadilah Abdul Wahi1 Cell Therclick here click here click here click here
Karen K BaBallen, KK;Departmentclick here click here click here click here
Scott R SoSolomon, SBlood and click here click here click here click here
Amir HamdHamdi, A; M
Departmentclick here click here click here click here
R Bassan Bassan, R;1] UOC Emat
click here click here click here click here
Y Y HwangHwang, YY; Mohty, M;click here click here click here click here
L Tucundu Tucunduva,1] Eurocord
click
AP-HP,
here University
click hereParis-Diderot,
click here click
Saint-Louis
here
Hos
Annalisa RRuggeri, A;Eurocord, Hclick here click here click here click here
Luciana TuTucunduva,Eurocord AP
click here click here click here click here
Patrice CheChevallier, Hematologyclick here click here click here click here
Massimo FMartelli, MFDivision of click here click here click here click here
Theis HelgTerwey, TH;Departmentclick here click here click here click here
John L Mike
Mikell, JL; Departmentclick here click here click here click here
Reiji FukanFukano, R;Departmentclick here click here click here click here
Olle Ringd Ringdn, O;1 Center foclick here click here click here click here
M Stern Stern, M; dImmunothera
click here click here click here click here
Aaron C L Logan, AC;Division of click here click here click here click here
Chen-Hua Yan, CH; JiPeking Univclick here click here click here click here
Ji Hyun Ki Kim, JH; StDepartmentclick here click here click here click here
Susan M HiHiniker, SMDepartmentclick here click here click here click here
Ling Ge Ge, L; Ye, Departmentclick here click here click here click here
Nirali N ShShah, NN; Pediatric Oclick here click here click here click here
S-H Shin Shin, SH; Departmentclick here click here click here click here
Sabine Na Naessn, SDepartmentclick here click here click here click here
321122634.xlsx

Article Type
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

24607554
24588540
24548609
24516895
24497539
24448864
24391118
24369228
24314630
24182818
24140121
24112249
24097633
24090598
24056740
24018394
24005245
23995098
23989431
23988403
23981652
23975518
23933760
23933757
23928857
23896629
23811537
23791626
23757212
23744585
23733511
23708705
23692373
23683419
23680867
23676649
23665820
23664940
23663336
23648236
23644077
23635453
23620000
23601986
23585892
23547077
23519958
23512868
23510508
23474804
23442062
23384118
23349309
23318533
23313065
23264126
23247660
23233608
23207728
23200706

http://www.sci-hub.io/10.1016/j.bbmt.2014.02.021
Survival imAdolescents
eng
Biology of Biol Blood 9600628 2014
Jun
http://www.sci-hub.io/10.1111/bjh.12810
TransplantaTransplantaeng
British jou Br J Haema0372544 2014
Jun
http://www.sci-hub.io/10.1016/j.clml.2014.01.002
The effect Allogeneic eng
Clinical l Clin Lymp 1015253862014
Aug
Donor selecAfter hemateng
Biology of Biol Blood 9600628 2014
Jan
http://www.sci-hub.io/10.1182/blood-2013-10-534297
The additioSirolimus heng
Blood
Blood
7603509 2014
Mar
http://www.sci-hub.io/10.4067/S0034-98872013000800014
0404312 2013
[Allogenic Public cordspa
Revista mRev Med Ch
Aug
http://www.sci-hub.io/10.1002/pbc.24918
Outcome ofWe report oeng
Pediatric b Pediatr Bl 1011866242014
Jun
CD56 expres
Bone marrow
eng
Journal of J Clin Exp 1011412572013
http://www.sci-hub.io/10.1016/j.leukres.2013.10.021
The role ofAdults witheng
Leukemia rLeuk Res 7706787 2014
Feb
http://www.sci-hub.io/10.1016/j.transproceed.2013.02.144
The impactSerum album
eng
Transplant Transplant 0243532 2013
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2013.10.010
Single infu Because ofeng
Biology of Biol Blood 9600628 2014
Jan
http://www.sci-hub.io/10.1111/ijlh.12153
Immunothera
To further define
eng the relative
Internation
impact
Int JofLab
immunotherapy
H1013002132014
and subsequent
Apr development of graft-ve
http://www.sci-hub.io/10.3324/haematol.2013.091009
0417435 2014
Umbilical cThere are veng
Haematolog
Haematolog
Feb
http://www.sci-hub.io/10.1016/j.bbmt.2013.09.015
MyeloablatiWe compared
eng
Biology of Biol Blood 9600628 2013
Dec
http://www.sci-hub.io/10.1038/bmt.2013.140
Reduced-int
We retrospe
eng
Bone marroBone Marro8702459 2013
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2013.08.013
Providing pPrediction eng
Biology of Biol Blood 9600628 2013
Nov
http://www.sci-hub.io/10.1038/leu.2013.259
Comparison
We report oeng
Leukemia Leukemia 8704895 2014
Apr
http://www.sci-hub.io/10.1038/bmt.2013.121
Pharmacokin
Allogeneic eng
Bone marroBone Marro8702459 2014
Jan
http://www.sci-hub.io/10.1038/leu.2013.253
Ph+ ALL pat
The efficaceng
Leukemia Leukemia 8704895 2014
Mar
http://www.sci-hub.io/10.1016/j.bbmt.2013.08.005
Individual The aim of eng
Biology of Biol Blood 9600628 2013
Dec
http://www.sci-hub.io/10.1016/j.transci.2013.07.030
Comparative
Due to the eng
TransfusionTransfus A 1010956532013
Dec
http://www.sci-hub.io/10.1007/s12185-013-1412-y
Comparable
Reports froeng
Internation Int J Hemat9111627 2013
Oct
http://www.sci-hub.io/10.1038/bmt.2013.111
MyeloablatiThe prognos
eng
Bone marroBone Marro8702459 2014
Feb
http://www.sci-hub.io/10.1038/bmt.2013.113
Early engraftment andeng
Bone marroBone Marro8702459 2014
Jan
http://www.sci-hub.io/10.1007/s00277-013-1862-6
Feasibility Clofarabineeng
Annals of Ann Hemat9107334 2013
Oct
http://www.sci-hub.io/10.1007/s00277-013-1847-5
Predictive The aim of eng
Annals of Ann Hemat9107334 2013
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2013.06.014
Unrelated dAllogeneic eng
Biology of Biol Blood 9600628 2013
Oct
http://www.sci-hub.io/10.1016/j.bbmt.2013.06.008
Outcomes Allogeneic
in
eng
Biology of Biol Blood 9600628 2013
Sep
http://www.sci-hub.io/10.1002/ajh.23502
Irreversibl Severe perieng
American j Am J Hema7610369 2013
Oct
http://www.sci-hub.io/10.1182/blood-2013-02-487074
CMV reactiv
The associa
eng
Blood
Blood
7603509 2013
Aug
http://www.sci-hub.io/10.1002/pbc.24559
Transplant-Over the laeng
Pediatric b Pediatr Bl 1011866242013
Sep
http://www.sci-hub.io/10.1038/bmt.2013.66
In haematop
The aim of eng
Bone marroBone Marro8702459 2013
Jul
http://www.sci-hub.io/10.1111/dme.12234
Late effect Childhood ceng
Diabetic meDiabet Med8500858 2013
Aug
http://www.sci-hub.io/10.3760/cma.j.issn.0253-2727.2013.03.008
[HaploidentTo observechi
Zhonghua xZhonghua X
8212398 2013
Mar
http://www.sci-hub.io/10.1007/s00277-013-1733-1
Combined Either
us
WT1eng
Annals of Ann Hemat9107334 2013
Aug
[Fatal zygoA 62-year-ojpn
[Rinsho ke Rinsho Ket2984782R 2013
Mar
http://www.sci-hub.io/10.1038/bmt.2013.68
Reduced-int
In this stu eng
Bone marroBone Marro8702459 2013
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2013.05.001
Reduced tox
Although reduced-intensity
eng
Biology
conditioning
of Biol Blood
has9600628
become standard
2013 of care
Aug for patients with hematol
7511141 2013
[Efficacies To comparechi
Zhonghua yZhonghua Y
Feb
http://www.sci-hub.io/10.1016/j.bbmt.2013.04.010
NelarabineT-ALL relapeng
Biology of Biol Blood 9600628 2013
Jul
http://www.sci-hub.io/10.1016/j.bbmt.2013.04.014
Outcomes For
of patienteng
Biology of Biol Blood 9600628 2013
Jul
http://www.sci-hub.io/10.1016/j.bbmt.2013.04.021
Pilot study Donor leuko
eng
Biology of Biol Blood 9600628 2013
Jul
http://www.sci-hub.io/10.1002/ajh.23465
Comparable
The role ofeng
American j Am J Hema7610369 2013
Aug
http://www.sci-hub.io/10.1179/1607845413Y.0000000088
Feasibility Haploidentieng
Hematology
Hematolog9708388 2014
Jan
http://www.sci-hub.io/10.1371/journal.pone.0061338
CD19 CAR-t
Although ma
eng
PloS one PLoS One 1012850812013
http://www.sci-hub.io/10.1200/JCO.2012.45.9719
Allogeneic Allogeneic eng
Journal of J Clin Onco8309333 2013
May
http://www.sci-hub.io/10.1002/pbc.24519
Self-report Chronic hea
eng
Pediatric b Pediatr Bl 1011866242013
Aug
http://www.sci-hub.io/10.1002/ajh.23439
Primary treAcute leukeeng
American j Am J Hema7610369 2013
Jun
http://www.sci-hub.io/10.1179/1607845413Y.0000000077
Features anMixed-lineaeng
Hematology
Hematolog9708388 2013
Nov
http://www.sci-hub.io/10.1038/bmt.2013.20
Allogeneic The best oueng
Bone marroBone Marro8702459 2013
Nov
http://www.sci-hub.io/10.3109/10428194.2013.779691
Comparison
Conditionineng
Leukemia Leuk Lymp9007422 2013
Nov
http://www.sci-hub.io/10.1111/bjh.12239
Criteria fo Most childreng
British jou Br J Haema0372544 2013
Apr
http://www.sci-hub.io/10.3324/haematol.2012.081877
0417435 2013
The clinicaThe biologyeng
Haematolog
Haematolog
Jun
http://www.sci-hub.io/10.1038/bmt.2012.261
Evidence foMyeloablatieng
Bone marroBone Marro8702459 2013
Jul
http://www.sci-hub.io/10.1016/j.clml.2012.12.003
Feasibility No highly eeng
Clinical l Clin Lymp 1015253862013
Jun
http://www.sci-hub.io/10.1007/s12185-012-1242-3
SuccessfulThe small cell
engvariant of
Internation
anaplastic
Intlarge
J Hemat
cell9111627
lymphoma2013
(ALCL) presents
Jan
in a nearly identical m
http://www.sci-hub.io/10.1093/annonc/mds615
NIH-defined
The prognos
eng
Annals of oAnn Oncol 9007735 2013
May
http://www.sci-hub.io/10.1182/asheducation-2012.1.382
When, how,Adult acuteeng
Hematology
Hematolog1008900992012
http://www.sci-hub.io/10.1159/000342897
Acute megak
Xerodermaeng
p
Acta haema
Acta Haema
0141053 2013
http://www.sci-hub.io/10.1016/j.bbmt.2012.11.015
Outcome ofThe therapeutic
eng efficacy
Biology
of allogeneic
of Biol Blood
peripheral
9600628
blood 2013
stem cell transplantation
Mar
(PBSCT) for he
321122634.xlsx

20
165
14
20
123
141
61
53
38
45
20
36
99
19
48
19
28
49
28
19
49
98
49
49
92
92
19
19
88
122
60
48
30
34
92
54
48
19
93
19
19
19
88
19
8
31
60
88
18
48
54
161
98
48
13
97
24
2012
129
19

6
5
4
1
13
8
6
3
2
9
1
2
2
12
12
11
4
1
3
12
3
4
2
1
10
12
10
9
10
7
9
7
8
3
8
3
11
8
8
7
7
7
8
1
4
13
8
6
6
11
11
1
6
7
3
1
5
2
3

829-36
688-98
319-26
98-105
2017-25
1064-7
1126-8
247-50
176-9
3371-4
58-65
197-204
378-84
1725-30
1513-8
1600-7
779-86
11-6
658-65
1670-6
590-9
456-62
287-91
145-7
1379-88
1685-93
1459-64
1374-80
853-7
1316-24
1520-7
908-14
e239-42
217-20
1111-9
311-5
1389-94
1167-74
583-7
1124-6
1059-64
1094-101
634-41
10-7
e61338
1669-76
1382-7
485-91
309-14
1369-76
2474-9
27-42
945-52
982-7
296-301
139-43
1363-70
382-8
121-5
495-9

Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Print
Internet
Print
Internet
Internet
Print
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet

William A Wood, WA;Division

L
of click here
Peter LangLang, P; TeChildren's click here
Yi Zhou Zhou, Y; SlDepartmentclick here
Huifen ZhoZhou, H; Bao, X; Wu, click here
Michael A PPulsipher, Division of click here
Francisco BBarriga, F; Wietstruck,click here
Johann K Hi
Hitzler, JK The Hospita
click here
Kazuo Muro
Muroi, K; FDivision of click here
K Paulson Paulson, KSection of click here
S Sivgin Sivgin, S; Departmentclick here
Dror MevorMevorach, The
D Rheuma
click here
C Curley Curley, C; Departmentclick here
Jos Luis Piana, JL;jlpinana@gclick here
Jaime San Sanz, J; Wa
Departmentclick here
H KanamorKanamori, D
Hepartmentclick here
Stephanie Lee, SJ; StFred Hutchiclick here
A Ruggeri Ruggeri, A;1] Eurocordclick here
G Kunter Kunter, G; 1] Departme
click here
V BachanoBachanova,Blood and click here
Francesco Lanza, F; CHematologyclick here
Hakan GokGoker, H; ODivision of click here
Xiaojin WuWu, X; He,Departmentclick here
M Eefting Eefting, M;Departmentclick here
click here
I Snchez-Snchez-Ort
1] Departme
Johanna TiTischer, J; Departmentclick here
Ho Sup Le Lee, HS; PDepartmentclick here
Song Yao Yao, S; HahDepartmentclick here
Andrew M Brunner, AM
Bone Marroclick here
Manabu KaKawakami,Departmentclick here
Margaret LGreen, ML;Vaccine anclick here
click here
Marion K MMateos, MK;
Kids Cancer
C Aristei Aristei, C; Radiation Oclick here
R RajendraRajendran,Departmentclick here
Zheng DonDong, Z; Hu
Institute o click here
Xiao-su ZhZhao, XS; Y
Peking Univclick here
Satoko KotKoteda, S; Departmentclick here
J Tanaka Tanaka, J; Departmentclick here
James L SlSlack, JL; Division o click here
Jia Chen Chen, J; WJiangsu Insclick here
Edouard F Forcade, E;Service d'Hclick here
Li Mei Poo Poon, LM; D
Hepartmentclick here
Anita J Ku Kumar, AJ;Abramson click
C here
Ki-Seong Eom, KS; SDepartmentclick here
Oscar GonzGonzlez-Llano, O; Roclick here
Marco L DaDavila, ML;Leukemia Sclick here
Mouhab AyAyas, M; Sa
King Faisa click here
Kay K Sun Sundberg, D
Kepartmentclick here
Anskar Y HLeung, AY; Departmentclick here
Cheng ZhaZhang, C; The Third M
click here
S NishiwakNishiwaki, Departmentclick here
Celalettin Eroglu, C; Departmentclick here
Jessica HoHochberg, Departmentclick here
David I MaMarks, DI; Adult BMT click
U here
P G Medd Medd, PG; Department
P
click here
Partow KebKebriaei, PDepartmentclick here
Rie ImamuImamura, R;
Division o click here
T H TerweyTerwey, TH;Departmentclick here
Hillard M LLazarus, HDepartmentclick here
Snjezana JJanjetovic, Departmentclick here
Mario DeliaDelia, M; PHematologyclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

23076550
23038972
22871557
22858507
22842330
22824185
22790635
22750645
22732703
22702414
22592050
22580767
22491731
22487659
22450582
22430088
22430085
22422899
22403503
22391715
22352263
22299728
22290459
22286683
22241156
22240733
22160835
22093587
22042561
22015993
21975786
21956640
21924223
21910644
21879292
21867666
21862339
21854085
21849486
21843495
21810970
21803017
21765478
21745455
21710165
21549217
21523798
21513557
21508120
21477348
21454468
21395356
21385623
21330213
21284831
21277378
21252987
21252669
21195315
21195314

http://www.sci-hub.io/10.1097/TP.0b013e31826c39b2
Factors witUmbilical ceng
TransplantaTransplanta0132144 2012
Nov
[Invasive mTo define t rus
Terapevtiche
Ter Arkh 2984818R 2012
http://www.sci-hub.io/10.1016/j.bbmt.2012.07.021
High alloreThe value oeng
Biology of Biol Blood 9600628 2013
Jan
http://www.sci-hub.io/10.1038/bmt.2012.147
QuantificatThe potentieng
Bone marroBone Marro8702459 2013
Mar
http://www.sci-hub.io/10.1016/j.bbmt.2012.07.017
FludarabineHematopoiet
eng
Biology of Biol Blood 9600628 2012
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2012.07.011
Allogeneic Allogeneic eng
Biology of Biol Blood 9600628 2012
Dec
[Hematopoietic stem cel
jpn
[Rinsho ke Rinsho Ket2984782R 2012
Jun
http://www.sci-hub.io/10.1016/j.bbmt.2012.06.010
ClofarabineWe investigeng
Biology of Biol Blood 9600628 2012
Dec
http://www.sci-hub.io/10.1038/bmt.2012.114
IntravenousWe investigeng
Bone marroBone Marro8702459 2013
Jan
http://www.sci-hub.io/10.1111/j.1600-0609.2012.01822.x
ClofarabineClofarabineeng
European jEur J Haem8703985 2012
Sep
http://www.sci-hub.io/10.1016/j.ijrobp.2012.03.033
Dose escala
We have dem
eng
Internation Int J Radia 7603616 2013
Jan
http://www.sci-hub.io/10.1038/bmt.2012.81
Anti-thymocRabbit antieng
Bone marroBone Marro8702459 2012
Dec
http://www.sci-hub.io/10.3324/haematol.2011.059378
0417435 2012
HaploidentiWe report aeng
Haematolog
Haematolog
Oct
http://www.sci-hub.io/10.1111/j.1601-5037.2012.00550.x
PeriodontalEvaluation eng
Internation Int J Dent 1011680702013
May
[B-cell acu A 61-year-ojpn
[Rinsho ke Rinsho Ket2984782R 2012
Feb
http://www.sci-hub.io/10.1016/j.bbmt.2012.02.012
Unrelated cData on preeng
Biology of Biol Blood 9600628 2012
Jun
http://www.sci-hub.io/10.1016/j.bbmt.2012.02.016
Radiation-fTotal body eng
Biology of Biol Blood 9600628 2012
Sep
http://www.sci-hub.io/10.1093/jjco/hys029
Phase II st To evaluateeng
Japanese jo
Jpn J Clin 0313225 2012
May
http://www.sci-hub.io/10.3904/kjim.2012.27.1.72
Feasibility This retros eng
The KoreanKorean J I 8712418 2012
Mar
http://www.sci-hub.io/10.1097/RLU.0b013e3182443b64
124I-anti-CD52 dosimet
eng
Clinical nu Clin Nucl 7611109 2012
Apr
Impact of sPeripheral eng
VojnosaniteVojnosanit 21530700R2011
Dec
http://www.sci-hub.io/10.1111/j.1365-2141.2012.09034.x
Growth factor-associated
This study analysed
eng graft-versus-host
the
British
effects
jouof
disease
Brgrowth
J Haema
and
factor
0372544
mortality
on outcome
10
2012
years
after
after
haematopoietic
Aprallogeneic bone
stem-cell
marrow
tran
tr
http://www.sci-hub.io/10.1002/ajh.23109
Safety and Disease releng
American j Am J Hema7610369 2012
Apr
9305754 2011
/S0716-10 [ImportanceA twenty fospa
Revista chilRev Chilena
Dec
[Bilateral r A 44-year-ojpn
[Rinsho ke Rinsho Ket2984782R 2011
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2011.12.587
Prophylactic and preem
eng
Biology of Biol Blood 9600628 2012
Apr
http://www.sci-hub.io/10.1007/s12185-011-0980-y
The role ofPatients wieng
Internation Int J Hemat9111627 2012
Jan
http://www.sci-hub.io/10.1016/j.hoc.2011.09.015
Cellular th ALL remains
eng
Hematology/
Hematol On8709473 2011
Dec
http://www.sci-hub.io/10.1007/s12185-011-0944-2
Outcome ofThe choiceeng
Internation Int J Hemat9111627 2011
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2011.10.016
Reduced-int
There are leng
Biology of Biol Blood 9600628 2012
May
http://www.sci-hub.io/10.1002/14651858.CD008818.pub2
Allogeneic Consolidatieng
The CochraCochrane D1009097472011
http://www.sci-hub.io/10.1007/s11864-011-0166-0
Redefining Assigning teng
Current treCurr Treat 1009009462011
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2011.08.024
HaploidentiThe outcome
eng
Biology of Biol Blood 9600628 2012
May
http://www.sci-hub.io/10.1089/scd.2011.0308
Donor bone marrow-deri
eng
Stem cells Stem Cells1011971072012
Jan
http://www.sci-hub.io/10.1007/s12185-011-0919-3
Sequential The prognos
eng
Internation Int J Hemat9111627 2011
Sep
http://www.sci-hub.io/10.1016/j.bbmt.2011.08.011
Long-term fThe introdueng
Biology of Biol Blood 9600628 2012
Apr
http://www.sci-hub.io/10.1016/j.jcms.2011.07.010
Imatinib-asPigmentatioeng
Journal of J Craniomax
8704309 2012
Jul
http://www.sci-hub.io/10.3109/10428194.2011.615424
Allogeneic Performingeng
Leukemia Leuk Lymp9007422 2012
Apr
http://www.sci-hub.io/10.1182/blood-2011-04-348540
7603509 2011
Safety and We report teng
Blood
Blood
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2011.08.007
Peripheral Many previo
eng
Biology of Biol Blood 9600628 2012
Apr
http://www.sci-hub.io/10.3324/haematol.2011.048348
Allogeneic stem cell t eng
Haematolog
Haematolog
0417435 2011
Aug
http://www.sci-hub.io/10.1016/j.bbmt.2011.07.019
The role ofClinical re eng
Biology of Biol Blood 9600628 2012
Jan
http://www.sci-hub.io/10.1038/bmt.2011.147
DecreasedWe
b measured
eng
Bone marroBone Marro8702459 2012
May
http://www.sci-hub.io/10.1016/j.bbmt.2011.06.015
Double redu
The purpose
eng
Biology of Biol Blood 9600628 2012
Feb
http://www.sci-hub.io/10.1007/s00277-011-1285-1
Monitoring This study eng
Annals of Ann Hemat9107334 2012
Feb
http://www.sci-hub.io/10.1016/j.bbmt.2011.04.003
i.v. busulfan
(BU) instead
the oral
9600628
formulation
outcomes in patients u
IntravenousThe use of eng
Biology
of Biol of
Blood
2011 can improve
Oct
http://www.sci-hub.io/10.1002/ajh.21989
Clinical ef The impacteng
American j Am J Hema7610369 2011
May
http://www.sci-hub.io/10.1186/1756-8722-4-19
Frequency Allogeneic
a
eng
Journal of J Hematol 1014689372011
http://www.sci-hub.io/10.3324/haematol.2011.040261
Non-myeloab
Allogeneic eng
Haematolog
Haematolog
0417435 2011
Aug
http://www.sci-hub.io/10.1186/1756-9966-30-36
Factors thaThere has b
eng
Journal of J Exp Clin 8308647 2011
http://www.sci-hub.io/10.1182/blood-2011-01-329003
Reduced-intensity vereng
Blood
Blood
7603509 2011
Mar
http://www.sci-hub.io/10.2165/11588950-000000000-00000
Pharmacothe
Acute lymph
eng
Drugs
Drugs
7600076 2011
Mar
http://www.sci-hub.io/10.1016/j.bbmt.2011.02.011
FludarabineWe aimed to
eng
Biology of Biol Blood 9600628 2011
Oct
http://www.sci-hub.io/10.1016/j.transci.2011.01.016
The role ofAcute lymph
eng
TransfusionTransfus A 1010956532011
Apr
http://www.sci-hub.io/10.1111/j.1751-553X.2010.01292.x
Evaluation Observation
eng
Internation Int J Lab H1013002132011
Aug
http://www.sci-hub.io/10.1016/j.bbmt.2011.01.010
Favorable oPhiladelphia
eng
chromosome-positive
Biology of Biol
acute
Blood
lymphoblastic
9600628 2011
leukemia (Ph(+)ALL)
Jul
is one of the highe
http://www.sci-hub.io/10.1038/leu.2010.319
Phase I tri We conducte
eng
Leukemia Leukemia 8704895 2011
Apr
http://www.sci-hub.io/10.1097/CCO.0b013e328342b82a
Reduced int
Use of a reeng
Current opiCurr Opin 9007265 2011
Mar
http://www.sci-hub.io/10.1016/j.bbmt.2010.11.024
Interpretin Until 10 to eng
Biology of Biol Blood 9600628 2011
Jan
http://www.sci-hub.io/10.1016/j.bbmt.2010.11.015
Transplants for the ol eng
Biology of Biol Blood 9600628 2011
Jan
321122634.xlsx

94
84
19
48
18
18
53
18
48
89
85
47
97
11
53
18
18
42
27
37
68
157
87
28
52
18
95
25
94
18
12
18
21
94
18
40
53
118
18
96
18
47
18
91
17
86
4
96
30
117
71
17
44
33
17
25
23
17
17

10
7
1
3
12
12
6
12
1
3
1
12
10
2
2
6
9
5
1
4
12
2
4
6
12
4
1
6
5
5
10
4
5
2
3
4
5
4
18
4
8
1
5
2
2
10
5
8
13
4
10
2
4
7
4
2
1 Suppl
1 Suppl

1066-74 Internet
50-7
Print
75-81
Internet
396-402 Internet
1921-6
Internet
1897-904 Internet
604-8
Print
1819-26 Internet
26-31
Internet
214-9
Internet
148-56
Internet
1513-9
Internet
1523-31 Internet
84-90
Internet
219-23
Print
963-8
Internet
1430-7
Internet
394-404 Internet
72-83
Internet
390-2
Internet
1026-32 Print
220-9
Internet
349-53
Internet
581-4
Print
1882-7
Print
652-4
Internet
95-101
Internet
1281-301 Internet
463-71
Internet
805-12
Internet
CD008818Internet
312-28
Internet
716-21
Internet
177-80
Internet
291-5
Internet
584-92
Internet
e140-3
Internet
550-6
Internet
4817-28 Internet
600-7
Internet
1083-6
Internet
18-36.e6 Internet
657-62
Internet
250-6
Internet
183-92
Internet
1555-61 Internet
399-405 Internet
19
Internet
1113-20 Internet
36
Internet
3698-9
Internet
415-42
Internet
1505-11 Internet
197-203 Internet
343-56
Internet
1093-7
Internet
599-605 Internet
197-202 Internet
S76-83
Internet
S71-5
Internet

Sofia Berg Berglund, SCentre for click here

click here
M O PopovPopova, MO; Zubarovsk
Maria Liga Liga, M; Tr Hematologyclick here
J Sanchez-Sanchez-Gar
Hematologyclick here
Andrew DalDaly, A; SaAlberta Bl click here
MohammadBakr, M; RaAdult Hemaclick here
Jin TakeuchTakeuchi, J
click here
Partow KebKebriaei, PDepartmentclick here
P Kebriaei Kebriaei, PDepartmentclick here
click here
Patrice CheChevallier, Centre Hosp
Jeffrey Y Wong, JY; D
F epartmentclick here
D A PortierPortier, DABone Marroclick here
Birgit Fed Federmann,
Medical Ceclick here
C A Grga Grgan, CA;
Departmentclick here
Yuiko TsukTsukada, Y;Division of click here
Veronika BBachanova,Blood and click here
Petros ChrChristopoulDepartmentclick here
Teruhisa A Azuma, T; TNational Caclick here
Ho Cheol SShin, HC; Departmentclick here
Daniel PutzPutzer, D; Departmentclick here
Dragana StStamatovi,Military Me click here
Olle Ringd Ringdn, O;Centre for click here
Takehiko MMori, T; Ai Division of click here
Teresa BidaBidart H, TComit de click here
Bungo SaitSaito, B; NDivision of click here
Giovanni CCaocci, G; Vacca, A; Lclick here
Glsan TrSucak, GT;Departmentclick here
Jae H ParkPark, JH; SLeukemia Sclick here
Akio ShigeShigematsu,
Stem Cell click here
Yi-Bin Che Chen, YB; A
Bone Marroclick here
Joseph PidPidala, J; Departmentclick here
Rob Sellar Sellar, R; Departmentclick here
Yu Wang Wang, Y; LPeking Univclick here
Yong-Xian Hu, YX; Luo, Y; Tan, click here
Kotaro Arit Arita, K; K Stem Cell Tclick here
Partow KebKebriaei, PDepartmentclick here
Renata GoResende, RDepartmentclick here
Satoshi NisNishiwaki, Departmentclick here
Renier J BrBrentjens, Departmentclick here
Mary D Th Thoma, MD;
Division o click here
Josep-MariRibera, JM
click here
Denise M OOliansky, DRoswell Parclick here
P Frisk
Frisk, P; A Departmentclick here
J O Bay Bay, JO; CaService de click here
Xiao-Su ZhZhao, XS; LPeking Univclick here
click here
Wei Tang Tang, W; WBlood and M
Kyoo-HyunLee, KH; CDepartmentclick here
Xiuli Wu Wu, X; Zhu,Institute o click here
Ron Ram Ram, R; StFred Hutchclick here
click here
Hideo Koh Koh, H; NaGraduate Sc
Satoshi NisNishiwaki, S; Inamoto click here
Mark R Lit Litzow, MRDepartmentclick here
Stella SantSantarone,Departmentclick here
K Paulson Paulson, K;University click here
J-F LesesvLesesve, JF
Departmentclick here
Yasushi OnOnishi, Y; Departmentclick here
S S Farag Farag, SS; Division of click here
Mitchell E Horwitz, M Duke Univeclick here
Jacob M RRowe, JM Departmentclick here
Rob S Sell Sellar, RS; Departmentclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

10

21200060
21193054
21193053
21182975
21170093
21151187
21138675
21114536
21052879
21035960
20979694
20882046
20861916
20854920
20716774
20685259
20625136
20622488
20425427
20421865
20404137
20376502
20199373
20146989
20118055
20089963
20040095
20009435
20008244
20008223
20008222
20007143
19959108
19837128
19822900
19822300
19778843
19706886
19648167
19617906
19608747
19581540
19563014
19494390
19440217
19430496
19388927
19350504
19298239
19212609
19179301
19147069
19141862
19099637
19041062
19025609
19023351
19011341
18988865
18955981

http://www.sci-hub.io/10.2146/ajhp100026
Systemic ab
A case of seng
American joAm J Healt9503023 2011
Jan
http://www.sci-hub.io/10.1016/j.bbmt.2010.12.702
As successeng
of reduced-intensity
(RIC) hematopoietic
stem cell transplantation (HS
Use of matc
Biology of conditioning
Biol Blood 9600628
2011
Aug
http://www.sci-hub.io/10.1016/j.bbmt.2010.12.704
Vitamin D lVitamin D (VD)
eng deficiency
Biology
canof
cause
Biol Blood
osteomalacia,
9600628bone
2011
pain, muscle
Jul weakness, fatigue, and
http://www.sci-hub.io/10.1016/j.bbmt.2010.12.699
Allogeneic A retrospeceng
Biology of Biol Blood 9600628 2011
Aug
http://www.sci-hub.io/10.1038/bmt.2010.314
BU- vs TBI-Evidence su
eng
Bone marroBone Marro8702459 2011
Nov
http://www.sci-hub.io/10.1038/bmt.2010.307
Glucose met
After SCT ieng
Bone marroBone Marro8702459 2011
Oct
http://www.sci-hub.io/10.3310/hta14540
Clinical ef Acute leukaeng
Health tec Health Tec 9706284 2010
Dec
http://www.sci-hub.io/10.1111/j.1600-0609.2010.01555.x
Reduced-intensity cord
eng
European jEur J Haem8703985 2011
Mar
http://www.sci-hub.io/10.1007/s12185-010-0714-6
Graft failu Graft failu eng
Internation Int J Hemat9111627 2010
Dec
http://www.sci-hub.io/10.1016/j.ijrobp.2010.06.029
Linear acceTo investig eng
Internation Int J Radia 7603616 2011
Mar
Risk factor Allogeneic eng
Chinese jouChin J Can1014982322010
Nov
http://www.sci-hub.io/10.1038/leu.2010.200
Antithymocy
This retros eng
Leukemia Leukemia 8704895 2010
Nov
http://www.sci-hub.io/10.1038/leu.2010.210
Late effect The Bone Ma
eng
Leukemia Leukemia 8704895 2010
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2010.09.006
Iron overlo Patients wieng
Biology of Biol Blood 9600628 2011
Jun
http://www.sci-hub.io/10.1182/blood-2010-02-266551
Reduced-int
This retros eng
Blood
Blood
7603509 2010
Nov
http://www.sci-hub.io/10.1016/j.bbmt.2010.05.007
ConditioninIn this prospective
eng
study
Biology
60 patients
of Biolof
Blood
median
9600628
age 46 2011
(range: 5-60
Mar
years), with acute myeloge
http://www.sci-hub.io/10.1200/JCO.2010.28.8852
Hematopoiet
Patients wieng
Journal of J Clin Onco8309333 2010
Aug
[Graft-vers A 19-year-ojpn
[Rinsho ke Rinsho Ket2984782R 2010
Jun
http://www.sci-hub.io/10.1007/s11899-009-0020-7
Allogeneic Allogeneic eng
Current he Curr Hemat1012625652009
Jul
http://www.sci-hub.io/10.1038/bmt.2010.85
AutologousThe treatme
eng
Bone marroBone Marro8702459 2011
Feb
http://www.sci-hub.io/10.1182/blood-2010-01-264077
The outcome
We examined
eng
Blood
Blood
7603509 2010
Jul
http://www.sci-hub.io/10.1007/s00467-010-1501-6
GlomerularWe evaluate
eng
Pediatric n Pediatr Ne 8708728 2010
Jul
Results of Over the paeng
Experimenta
Exp Clin Tr1012073332010
Mar
http://www.sci-hub.io/10.1684/ecn.2009.0181
Early pre-ePrevious steng
European cEur Cytoki 9100879 2010
Mar
Immunohemat
Immunohemat
eng
Hematology
Hematol On1014685322009
http://www.sci-hub.io/10.1182/blood-2009-09-244525
The detectiDonor-direceng
Blood
Blood
7603509 2010
Apr
http://www.sci-hub.io/10.1186/1756-8722-2-51
Autonomous
We have des
eng
Journal of J Hematol 1014689372009
SuccessfulThe prognos
eng
[Rinsho ke Rinsho Ket2984782R 2009
Nov
http://www.sci-hub.io/10.1182/asheducation-2009.1.593
TransplantaThe value oeng
Hematology
Hematolog1008900992009
http://www.sci-hub.io/10.1182/asheducation-2009.1.371
Management
The tyrosineng
Hematology
Hematolog1008900992009
http://www.sci-hub.io/10.1182/asheducation-2009.1.362
Evolving paImportant seng
Hematology
Hematolog1008900992009
http://www.sci-hub.io/10.3324/haematol.2009.011809
A modified Disease staeng
Haematolog
Haematolog
0417435 2010
May
http://www.sci-hub.io/10.1016/j.beha.2009.10.006
Role of redAlthough aleng
Best practi Best Pract 1011206592009
Dec
http://www.sci-hub.io/10.1016/j.exphem.2009.10.007
SuccessfulXenogeneiceng
ExperimentExp Hemat0402313 2010
Jan
http://www.sci-hub.io/10.1182/blood-2009-07-228999
7603509 2010
Single-unit We investigeng
Blood
Blood
Jan
http://www.sci-hub.io/10.1016/j.bbmt.2009.07.003
Reduced-int
Acute lymph
eng
Biology of Biol Blood 9600628 2009
Nov
http://www.sci-hub.io/10.3816/CLM.2009.s.014
TransplantaThe large Meng
Clinical l Clin Lymp 1012565002009
http://www.sci-hub.io/10.1182/blood-2009-05-220525
Relapse risUmbilical ceng
Blood
Blood
7603509 2009
Nov
http://www.sci-hub.io/10.3324/haematol.2009.008649
0417435 2009
Favorable oApproximate
eng
Haematolog
Haematolog
Oct
http://www.sci-hub.io/10.1038/bmt.2009.168
Allo-SCT for hematolog
eng
Bone marroBone Marro8702459 2010
Mar
http://www.sci-hub.io/10.1182/blood-2009-03-208355
Donor, reciWe report oeng
Blood
Blood
7603509 2009
Sep
http://www.sci-hub.io/10.1200/JCO.2008.20.2960
MyeloablatiAnalysis ofeng
Journal of J Clin Onco8309333 2009
Aug
[Clinical s To explore chi
Zhonghua xZhonghua X
8212398 2009
Feb
Haematopoie
In Taiwan, eng
Hong KongHong Kong9512509 2009
Jun
http://www.sci-hub.io/10.1038/leu.2009.102
Reduced-int
The aim of eng
Leukemia Leukemia 8704895 2009
Oct
http://www.sci-hub.io/10.1038/bmt.2009.83
FludarabineIn this pro eng
Bone marroBone Marro8702459 2009
Dec
http://www.sci-hub.io/10.1111/j.1365-2141.2009.07666.x
Impact of t Acute lymph
eng
British jou Br J Haema0372544 2009
Jun
http://www.sci-hub.io/10.3760/cma.j.issn.1003-9406.2009.02.006
[Identifica To explore chi
Zhonghua yi
Zhonghua Y
9425197 2009
Apr
http://www.sci-hub.io/10.1111/j.1399-3062.2009.00379.x
Infectious Bacterial, eng
Transplant Transpl Inf 1008836882009
Jun
7609387 2009
[MyeloablatTumour necr
ger
Nuklearmed
Nuklearmed
http://www.sci-hub.io/10.1182/blood-2008-10-184093
Prolonged sTwenty-twoeng
Blood
Blood
7603509 2009
Mar
http://www.sci-hub.io/10.1016/j.bbmt.2008.11.017
TransplantsThe large Meng
Biology of Biol Blood 9600628 2009
Jan
http://www.sci-hub.io/10.1182/blood-2008-11-185132
7603509 2009
Improved riClinical ri eng
Blood
Blood
Apr
[Comparativ
This study chi
Zhongguo sh
Zhongguo S
1010844242008
Dec
http://www.sci-hub.io/10.1016/j.bbmt.2008.09.021
Allogeneic We studiedeng
Biology of Biol Blood 9600628 2008
Dec
http://www.sci-hub.io/10.1186/1756-9966-27-74
Prognostic The aim of eng
Journal of J Exp Clin 8308647 2008
[AllogeneicThe success
nor
Tidsskrift Tidsskr No 0413423 2008
Nov
[Limited buWe presentjpn
Gan to kagGan To Ka 7810034 2008
Nov
http://www.sci-hub.io/10.1182/blood-2008-07-168625
MyeloablatiW hile commo
eng
Blood
Blood
7603509 2009
Feb
http://www.sci-hub.io/10.1038/bmt.2008.347
Unrelated cWe analyzed
eng
Bone marroBone Marro8702459 2009
Mar
321122634.xlsx

11

68
17
17
17
46
46
14
86
92
79
29
24
24
17
116
17
28
51
4
46
116
25
8
21
2
115
2
50

2
8
7
8
11
10
54
3
5
4
11
11
12
6
22
3
23
6
3
2
3
7
1
1
2
13

135-7
1196-204
1079-83
1187-95
1413-7
1303-8
iii-iv, ix-xi,
268-71
744-50
1256-65
946-51
1867-74
2039-47
852-60
4439-43
341-50
3730-8
413-21
139-47
217-26
366-74
1337-42
61-5
40-9
320-32
2704-8
51
11
1612-5
593-601
371-81
362-70
95
5
810-8
22
4
557-66
38
1
3-10
115
4
757-65
15
11
1407-14
9 Suppl 3
S211-3
114
19
4293-9
94
10
1399-406
45
3
584-6
114
13
2606-16
27
22
3634-41
30
2
73-6
15
3 Suppl 3 13-6
23
10
1763-70
44
12
785-92
145
5
581-97
26
2
147-50
11
3
220-6
48
1
30-6
113
13
2902-5
15
1 Suppl 7-10
113
18
4153-62
16
6
1325-9
14
12
1394-400
27
74
128
22
2563-6
35
11
1911-4
113
6
1375-82
43
6
455-9

Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Print
Internet
Internet
Internet
Internet
Internet
Internet
Print
Internet
Internet
Internet
Internet
Internet
Internet
Print
Internet
Internet
Print
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Internet
Print
Print
Internet
Internet
Internet
Print
Internet
Print
Internet
Internet
Internet
Print
Internet
Internet
Internet
Print
Internet
Internet

Bichoy H GGabra, BH;Karmanos click

Ca here
Vincent T Ho, VT; KimCenter for click here
Lisa SproatSproat, L; Banner Bloclick here
Kristine D Doney, K; Clinical R click here
M KalaycioKalaycio, MDepartmentclick here
P Frisk
Frisk, P; R Departmentclick here
K Ashfaq Ashfaq, K; West Midlan
click here
Toshimitsu Ueki, T; Sumi, M; Sat click here
Masahiko Sumi, M; Sh
Departmentclick here
Mete YeginYeginer, M Center for click here
Zheng-PingYu, ZP; DinDepartmentclick here
M Mohty Mohty, M; LHematologyclick here
K S Baker Baker, KS; Clinical R click here
Philippe A Armand, P;Departmentclick here
Mohamad M
Mohty, M; LService d'Hclick here
Eneida R Nemecek, ER
Oregon Hea
click here
click here
Michel DuvDuval, M; KCentre Hosp
Kenichi NaNagai, K; HDepartmentclick here
Theis H TeTerwey, TH;Departmentclick here
A Balduzzi Balduzzi, AClinica Pedclick here
David I MaMarks, DI; University click here
Per Frisk Frisk, P; A Unit of Pedclick here
Mani RamzRamzi, M; Departmentclick here
Knut LisethLiseth, K; The Blood click here
Lucille Wo Wood, L; Ha
Division of click here
Stephen SpSpellman, S
National M click here
Ying Yan Yan, Y; WieThe Saint click here
Nobuhiko IMAHASHI,Departmentclick here
Anthony H Goldstone,UCL Hospitclick here
Oliver G O Ottmann, OG
Medizinischclick here
Mark R Lit Litzow, MRDivision o click here
Theis H TeTerwey, TH;Departmentclick here
Stephen J Forman, S Departmentclick here
Alice M S Cheung, AM
Departmentclick here
Jonathan Gutman, JA;
Division o click here
Anthony S Stein, AS; Departmentclick here
Anthony H Goldstone,Departmentclick here
Michael R Verneris, MDepartmentclick here
Bella PatelPatel, B; K Departmentclick here
M N PolizzoPolizzotto, MN; Skinneclick here
Michael A PPulsipher, University click here
Michael B Tomblyn, MB
Departmentclick here
Xiao Ma Ma, X; Wu,Departmentclick here
P M Chen Chen, PM; Division
H
of click here
B-S Cho Cho, BS; LDepartmentclick here
F Zohren Zohren, F; Departmentclick here
Franz GrubGruber, F; Departmentclick here
Xuan Du Du, X; Liu, Departmentclick here
C T RiegerRieger, CT;Departmentclick here
J MutschleMutschler, Klinik fr click here
Veronika BBachanova,Blood and click here
Anthony H Goldstone,Departmentclick here
Renato Ba Bassan, R;Unit Strut click here
Yu-Shi BaoBao, YS; J Institute click here
Priya KumaKumar, P; D
Blood and click here
Kourosh SaSayehmiri, Departmentclick here
Yngvar FlFlisand, YSeksjon forclick here
Osamu ImaImataki, O;Division of click here
Jan J CornCornelissenDepartmentclick here
J Ooi
Ooi, J; Tak Departmentclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

12

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

13

18946578
18940679
18783387
18724392
18711350
18589156
18562004
18500370
18410899
18378566
18334992
18334991
18310967
18285674
18273047
18246116
18245655
18209719
18179047
18176612
18084336
18084335
18055985
18026156
18024663
17968329
17961726
17933709
17926001
17905610
17867298
17802787
17673900
17673057
17618317
17580259
17572712
17488684
17468775
17430661
17382257
17348813
17313562
17277788
17264526
17241929
17176317
17162211
17094576
17064985
17060849
16965686
16928623
16917917
16892073
16799614
16798251
16732860
16679917
16649348

Stem cell t To describeeng

Saudi medic
Saudi Med 7909441 2008
http://www.sci-hub.io/10.1016/j.bbmt.2008.08.010
Comparable
HLA-matched
eng
Biology of Biol Blood 9600628 2008
http://www.sci-hub.io/10.1111/j.1432-2277.2008.00749.x
Demodicidosis as a cau
eng
Transplant Transpl Int 8908516 2008
http://www.sci-hub.io/10.1038/bmt.2008.256
Long-term lymphoid-res
eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1038/bmt.2008.258
Allogeneic We presenteng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1016/j.transproceed.2007.11.077
Cardiac sysOne hundred
eng
Transplant Transplant 0243532 2008
http://www.sci-hub.io/10.1016/j.ophtha.2008.04.015
Cytomegalov
To report oeng
OphthalmoOphthalmo7802443 2008
http://www.sci-hub.io/10.1038/bmt.2008.155
Lack of uti Lineage-spe
eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1016/j.bbmt.2008.02.018
Excellent oWe retrospe
eng
Biology of Biol Blood 9600628 2008
http://www.sci-hub.io/10.1200/JCO.2007.15.0169
Individual Previous steng
Journal of J Clin Onco8309333 2008
http://www.sci-hub.io/10.1038/bmt.2008.1
Allogeneic Allogeneic eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1038/bmt.2008.21
The role of allograftin eng
Bone marroBone Marro8702459 2008
Thiotepa/cyTo reduce teng
Internal meIntern Med 9204241 2008
Allogeneic In allogeneeng
The TohokuTohoku J E0417355 2008
http://www.sci-hub.io/10.1038/leu.2008.10
Long-term molecular ceng
Leukemia Leukemia 8704895 2008
http://www.sci-hub.io/10.1038/sj.bmt.1705994
Umbilical cAllogeneic eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.3324/haematol.11960
0417435 2008
Reduced int
This retros eng
Haematolog
Haematolog
http://www.sci-hub.io/10.1038/sj.bmt.1705989
A fludarabi We presenteng
Bone marroBone Marro8702459 2008
Hematopoiet
Hematopoiet
eng
Oncology (W
Oncology (W
8712059 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705966
HaploidentiWork on one
eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1038/sj.bmt.1705949
Emergency double unrel
eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1038/sj.bmt.1705952
Long-term o
For adults eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.3324/haematol.10882
Outcome ofT-lymphobla
eng
Haematolog
Haematolog
0417435 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705898
Donor leuko
Allogeneic eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1182/asheducation-2007.1.444
Which patieThe decisioeng
Hematology
Hematolog1008900992007
http://www.sci-hub.io/10.1038/sj.bmt.1705889
Unrelated dAcute lymph
eng
Bone marroBone Marro8702459 2008
http://www.sci-hub.io/10.1053/j.seminhematol.2007.08.004
Post-remissAllogeneic eng
Seminars i Semin Hem0404514 2007
Triple anti Systemic ca
eng
European jo
Eur J Med 9517857 2007
http://www.sci-hub.io/10.1007/s15010-007-6350-2
Infectious Infectious eng
Infection Infection 0365307 2007
http://www.sci-hub.io/10.1016/j.bcmd.2007.07.004
The haploidMuch progre
eng
Blood cellsBlood Cells9509932
[Benefits o We retrospe
jpn
[Rinsho ke Rinsho Ket2984782R 2007
[TransplantTo analyse rus
Terapevtiche
Ter Arkh 2984818R 2007
http://www.sci-hub.io/10.1038/sj.leu.2404892
Rapid naturNatural kil eng
Leukemia Leukemia 8704895 2007
http://www.sci-hub.io/10.4065/82.8.907
Regurgitation of eso eng
Mayo Clini Mayo Clin 0405543 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705769
Non-myeloab
Using non-m
eng
Bone marroBone Marro8702459 2007
http://www.sci-hub.io/10.1016/j.bbmt.2007.03.003
Allogeneic A myeloabla
eng
Biology of Biol Blood 9600628 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705734
Long-term rWe analyzed
eng
Bone marroBone Marro8702459 2007
Clearance o
The molecul
eng
Haematolog
Haematolog
0417435 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705685
FludarabineBusulfan aneng
Bone marroBone Marro8702459 2007
[PeripheralHematopoiet
chi
Ai zheng = Ai Zheng 9424852 2007
http://www.sci-hub.io/10.1016/j.bbmt.2006.12.450
Unrelated stem cell tr eng
Biology of Biol Blood 9600628 2007
http://www.sci-hub.io/10.1089/scd.2006.06500-HB
Multiple unWe investigeng
Stem cells Stem Cells1011971072007
http://www.sci-hub.io/10.1111/j.1600-0609.2006.00797.x
Graft rejec Human leuko
eng
European jEur J Haem8703985 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705594
Allogeneic We assessed
eng
Bone marroBone Marro8702459 2007
http://www.sci-hub.io/10.1159/000098229
Fatal leukoToxicity as eng
Onkologie Onkologie 7808556 2007
http://www.sci-hub.io/10.1016/j.bbmt.2006.10.005
IntravenousResults of eng
Biology of Biol Blood 9600628 2007
http://www.sci-hub.io/10.1111/j.1537-2995.2006.01032.x
Outcomes Umbilical
of
ceng
Transfusio Transfusio 0417360 2006
http://www.sci-hub.io/10.1016/j.bbmt.2006.07.014
Safety and The use of eng
Biology of Biol Blood 9600628 2006
[Acute lympA 42-year-ojpn
[Rinsho ke Rinsho Ket2984782R 2006
http://www.sci-hub.io/10.1080/10428190600632857
ExtramedullRecurrent oeng
Leukemia Leuk Lymp9007422 2006
http://www.sci-hub.io/10.1097/01.tp.0000235859.24513.43
Low number
The effect eng
TransplantaTransplanta0132144 2006
[Clinical s Allogeneic chi
Ai zheng = Ai Zheng 9424852 2006
http://www.sci-hub.io/10.1080/08860220600781393
Chronic renChronic proeng
Renal failuRen Fail 8701128 2006
http://www.sci-hub.io/10.1002/ajh.20706
Hiccups and severe hyeng
American j Am J Hema7610369 2007
http://www.sci-hub.io/10.1038/sj.bmt.1705464
Alternative Myeloablatieng
Bone marroBone Marro8702459 2006
http://www.sci-hub.io/10.1038/sj.bmt.1705425
Allogeneic We explored
eng
Bone marroBone Marro8702459 2006
http://www.sci-hub.io/10.1016/j.athoracsur.2005.09.043
Treatment o
We describe
eng
The AnnalsAnn Thorac15030100R2006
http://www.sci-hub.io/10.1111/j.1445-5994.2006.01079.x
Unrelated uA number of
eng
Internal meIntern Med 1010929522006
http://www.sci-hub.io/10.1097/01.mph.0000212902.84146.81
Hematopoiet
Relapsed ac
eng
Journal of J Pediatr 9505928 2006
Effects of The coexisteng
Archives ofArch Iran 1008896442006
321122634.xlsx

Oct
Nov
Dec
Dec
Dec
Jun
Oct
Aug
May
May
Mar
Mar
Feb
Aug
Mar
Feb
May
Nov
Mar
Apr
Apr
Dec
Mar
Mar
Oct
Aug
Dec
2008 JanAug
Oct
Aug
Sep
Jul
Aug
May
Jul
Apr
Apr
Feb
Feb
Mar
Feb
Feb
Dec
Dec
Oct
Sep
Oct
Aug
Jan
Oct
Aug
Jul
Jun
Apr
Apr

14

29
14
21
42
42
40
115
42
14
26
41
41
47
214
22
41
93
41
21
41
41
41
92
41

10
11
12
12
12
5
10
4
5
13
5
5
5
2
8
5
2
10
13
5
7
7
12
5

41
44
12
35
40
48
79
21
82
40
13
40
92
40
26
13
16
78
39
30
13
46
12
47
47
82
25
28
82
38
38
82
36
28
9

5
4
8
6
1
8
7
10
8
6
7
4
5
2
4
4
1
2
6
1-2
2
12
12
10
9
8
8
6
1
7
3
1
6
4
2

1484-9
Print
1245-52 Internet
1192-3
Print
829-31
Internet
791-8
Internet
1586-90 Print
1766-70 Internet
271-4
Print
568-75
Internet
2162-70 Internet
439-46
Print
413-4
Print
379-83
Internet
159-63
Print
1617-8
Internet
465-72
Print
303-6
Internet
845-50
Print
1576-83; dPrint
473-81
Print
675-6
Print
635-42
Print
1623-30 Internet
483-93
Print
444-52
Print
455-64
Print
267-73
Print
337-40
Print
421-7
Print
8-12
Print
624-31
Print
30-5
Print
2145-52 Print
907
Print
535-9
Print
814-21
Print
339-47
Print
612-8
Internet
105-10
Print
403-6
Print
494-7
Print
177-86
Print
157-60
Print
341-6
Print
49-52
Print
235-44
Print
2063-70 Print
1295-301 Print
1372-6
Print
1754-67 Print
1024-30 Print
1019-22 Print
519-22
Print
88
Print
467-75
Print
203-9
Print
338-40
Internet
355-61
Internet
210-5
Print
99-103
Print

Maha M El-El-Zimaity Departmentclick here

Alana A KeKennedy-Na
Center for click here
Yoshinobu Aisa, Y; Mori, T; Tani click here
A SpyridoniSpyridonidis, A; Bertz click here
T H TerweyTerwey, TH;Departmentclick here
G T Sucak Sucak, GT;Departmentclick here
Won KyungSong, WK;Departmentclick here
Kc Doney Doney, K; LClinical R click here
Akio ShigeShigematsu,
Departmentclick here
Stephanie Lee, SJ; JoDivision of click here
A Stein
Stein, A; F Departmentclick here
D I Marks Marks, DI
click here
KatsumichiFujimaki, KDepartmentclick here
Toshihiko Ando, T; YuThird Deparclick here
P P Piccal Piccaluga, PP; Martinel
click here
W W Tse Tse, WW; ZDivision o click here
Mohamad M
Mohty, M; LService d' click here
C Grllich Grllich, C;Departmentclick here
Gabriela BaBallester, Edwards Co
click here
F Aversa Aversa, F Haematopoie
click here
C Sarkode Sarkodee-Adoo, C; Alva
click here
M R Bisho Bishop, MR;
Experimenta
click here
Mathilde HHunault, M;Haematolog
click here
A W Loren Loren, AW;Bone Marroclick here
Hillard M LLazarus, HIreland Ca click here
V BachanoBachanova,Departmentclick here
Roel Wille Willemze, R
Departmentclick here
B Gahn Gahn, B; SDivision o click here
L Gil
Gil, L; Sty Departmentclick here
Franco AveAversa, F; Departmentclick here
Masaki MorMori, M; MuDivision of click here
V G SavchSavchenko, VG; Liubim
click here
B N SavaniSavani, BN;Stem Cell Tclick here
Benjamin GGesundheit,
Departmentclick here
C H GutierrGutierrez- Servicio declick here
James A RuRussell, JAAlberta Bl click here
C S Chim Chim, CS; Departmentclick here
Orietta SpinSpinelli, O Hematologyclick here
M Iravani Iravani, M; Hematologyclick here
Xin-Sheng Xie, XS; Wa
Departmentclick here
J F Lacerd Lacerda, JF; Martins, click here
John ListerLister, J; Division o click here
Hirokazu Okumura, H;
Departmentclick here
A Bacigalu Bacigalupo,Divisione dclick here
Stephan MiMielke, S; Departmentclick here
Trudy N SmSmall, TN; Departmentclick here
Karen K BaBallen, KK;American Rclick here
R Or
Or, R; HadaDepartmentclick here
Shuichiro Takashima,Medicine aclick here
Isabel CunCunningham
Jacobi Medclick here
Nicolaus KKrger, N; Bone Marroclick here
Ai-Ning SuSun, AN; WThe First Aclick here
Hiroshi NisNishi, H; Departmentclick here
V Lazarevi Lazarevic, V; Hgg, E;click here
D I Marks Marks, DI; Adult BMT click
U here
P Kebriaei Kebriaei, PDepartmentclick here
Subroto PaPaul, S; MaDivision o click here
K F Bradst Bradstock, Blood and click here
Eric S SandSandler, ESDepartmentclick here
Kamran Al Alimoghadda
Hematologyclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

15

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

16

16545728
16518422
16461327
16417095
16399566
16284608
16275419
16273115
16266913
16258531
16254705
16247429
16213741
16162110
16146548
16145067
16132912
16113673
16113659
15995714
15983427
15978741
15972120
15949287
15931633
15929135
15821769
15756282
15682076
15646659
15555258
15485779
15448665
15359997
15353134
15344959
15344953
15322568
15256423
15254049
15221628
15203867
15195078
15183902
15077223
15003889
14993885
14990046
14989709
14962258
14726405
14663161
14564178
12972995
12969813
12953124
12900781
12900778
12869961
12869959

http://www.sci-hub.io/10.1016/j.bbmt.2005.12.029
A compariso
We compared
eng
Biology of Biol Blood 9600628 2006
http://www.sci-hub.io/10.1038/sj.bmt.1705334
Unrelated cord blood teng
Bone marroBone Marro8702459 2006
Targeted ma
We treatedeng
Haematolog
Haematolog
0417435 2006
[PregnancyThere are rpol
Ginekologi Ginekol Po0374641 2005
http://www.sci-hub.io/10.1016/j.bbmt.2005.10.018
The role ofEvidence su
eng
Biology of Biol Blood 9600628 2006
http://www.sci-hub.io/10.1038/sj.bmt.1705221
Comparable
We report teng
Bone marroBone Marro8702459 2006
http://www.sci-hub.io/10.1016/j.blre.2004.09.002
Immunothera
Acute lymph
eng
Blood revi Blood Rev 8708558 2005
http://www.sci-hub.io/10.1038/sj.bmt.1705200
Alternative Children wieng
Bone marroBone Marro8702459 2006
Mucormycose
Mucormycose
eng
Haematolog
Haematolog
0417435 2005
http://www.sci-hub.io/10.1038/sj.bmt.1705207
Allogeneic We examined
eng
Bone marroBone Marro8702459 2006
http://www.sci-hub.io/10.1007/s00066-005-1405-8
Renal dysfuA retrospeceng
StrahlentheStrahlenth 8603469 2005
http://www.sci-hub.io/10.1038/sj.bmt.1705185
Rapid respo
We evaluate
eng
Bone marroBone Marro8702459 2005
http://www.sci-hub.io/10.1016/j.critrevonc.2005.03.016
Allogeneic The majoriteng
Critical re Crit Rev O 8916049 2005
http://www.sci-hub.io/10.1111/j.1432-2277.2005.00204.x
Altered metTacrolimus eng
Transplant Transpl Int 8908516 2005
http://www.sci-hub.io/10.1111/j.1399-0012.2004.00313.x
Repetitive Informationeng
Clinical tra Clin Transp8710240 2005
http://www.sci-hub.io/10.1200/JCO.2005.01.7269
Outcome ofWe previous
eng
Journal of J Clin Onco8309333 2005
http://www.sci-hub.io/10.1007/s00277-005-1067-8
Mesenchymal
Mesenchymal
eng
Annals of Ann Hemat9107334 2005
http://www.sci-hub.io/10.1038/sj.bmt.1705123
Survival af To assess teng
Bone marroBone Marro8702459 2005
http://www.sci-hub.io/10.1038/sj.bmt.1705148
MyeloablatiDisease-freeng
Bone marroBone Marro8702459 2005
http://www.sci-hub.io/10.1038/sj.bmt.1705075
Reduced-int
Reduced-int
eng
Bone marroBone Marro8702459 2005
http://www.sci-hub.io/10.1159/000084674
RetrospectiThis retros eng
Acta haema
Acta Haema
0141053 2005
http://www.sci-hub.io/10.1016/j.ijrobp.2005.04.020
Utility of c Total body eng
Internation Int J Radia 7603616 2005
[CytogenetiTo explore chi
Zhongguo sh
Zhongguo S
1010844242005
8212398 2005
[Reduced inTo evaluatechi
Zhonghua xZhonghua X
http://www.sci-hub.io/10.1016/j.bbmt.2005.03.007
Intensive t To improveeng
Biology of Biol Blood 9600628 2005
http://www.sci-hub.io/10.1002/pbc.20414
Cord bloodOptimal theeng
Pediatric b Pediatr Bl 1011866242005
http://www.sci-hub.io/10.1038/sj.bmt.1704956
CyclosporinThe combina
eng
Bone marroBone Marro8702459 2005
http://www.sci-hub.io/10.1038/sj.bmt.1704776
Reduced-int
Efficacy of eng
Bone marroBone Marro8702459 2005
http://www.sci-hub.io/10.1016/j.bbmt.2004.11.020
Umbilical cThe Cord Bl
eng
Biology of Biol Blood 9600628 2005
PhiladelphiA 32-year-oeng
Internation Int J Hemat9111627 2004
8212398 2004
[Mismatched
To explore chi
Zhonghua xZhonghua X
[Effects of To explore chi
Di 1 jun yi Di Yi Jun 9426110 2004
http://www.sci-hub.io/10.1038/sj.thj.6200543
Nonmyeloabl
28 patientseng
The hematol
Hematol J 1009655232004
Hematopoiet
The role ofeng
Leukemia Leuk Lymp9007422 2004
http://www.sci-hub.io/09.2004/JCPSP.522526
Allogeneic To report t eng
Journal of J Coll Phys9606447 2004
http://www.sci-hub.io/10.1111/j.1399-0012.2004.00225.x
Efficacy of A combinatieng
Clinical tra Clin Transp8710240 2004
http://www.sci-hub.io/10.1111/j.1399-0012.2004.00198.x
Effect of c Recipients eng
Clinical tra Clin Transp8710240 2004
http://www.sci-hub.io/10.1038/sj.bmt.1704645
Second tran
Treatment o
eng
Bone marroBone Marro8702459 2004
http://www.sci-hub.io/10.1182/blood-2003-10-3560
7603509 2004
Better outcVarious traeng
Blood
Blood
http://www.sci-hub.io/10.1200/JCO.2004.07.130
Outcome ofThe role ofeng
Journal of J Clin Onco8309333 2004
http://www.sci-hub.io/10.1007/s10072-004-0237-0
Busulfan neA 21-year-oeng
NeurologicaNeurol Sci 1009591752004
http://www.sci-hub.io/10.1080/10245330310001652509
Second alloBetween Mar
eng
Hematology
Hematolog9708388 2004
http://www.sci-hub.io/10.1038/sj.bmt.1704575
High-dose cOne approac
eng
Bone marroBone Marro8702459 2004
http://www.sci-hub.io/10.1016/S0268-960X(03)00063-8
HaploidentiHaploidentieng
Blood revi Blood Rev 8708558 2004
http://www.sci-hub.io/10.1016/j.bbmt.2003.11.005
A pilot stu Tacrolimus eng
Biology of Biol Blood 9600628 2004
0417435 2004
GIMEMA ALL
The outcome
eng
Haematolog
Haematolog
http://www.sci-hub.io/10.1016/j.bbmt.2003.11.002
Graft-versuTo determineng
Biology of Biol Blood 9600628 2004
[AllogeneicTo retrospechi
Zhonghua xZhonghua X
8212398 2004
http://www.sci-hub.io/10.1111/j.0001-2815.2004.00182.x
The beneficHLA allele eng
Tissue ant Tissue Ant 0331072 2004
http://www.sci-hub.io/10.1046/j.0902-4441.2004.00172.x
Dendritic c We have ana
eng
European jEur J Haem8703985 2004
http://www.sci-hub.io/10.1182/blood-2003-08-2815
Hemorrhagic
Hemorrhagic
eng
Blood
Blood
7603509 2004
74221
Results of Methods toeng
Acta haema
Acta Haema
0141053 2003
Acute lymph
It is still
eng
Current opiCurr Opin 9430802 2003
http://www.sci-hub.io/10.1097/01.rlu.0000082660.35154.55
Re-186 HEDP
The authors
eng
Clinical nu Clin Nucl 7611109 2003
A low bodyThe purpose
eng
Haematolog
Haematolog
0417435 2003
http://www.sci-hub.io/10.1038/sj.bmt.1704198
Randomized
Conditionineng
Bone marroBone Marro8702459 2003
http://www.sci-hub.io/10.1038/sj.bmt.1704179
MyeloablatiHematologic
eng
Bone marroBone Marro8702459 2003
http://www.sci-hub.io/10.1038/sj.bmt.1704149
Changes ofInsulin-lik eng
Bone marroBone Marro8702459 2003
Predictive Between Jan
eng
Biology of Biol Blood 9600628 2003
Low-dose to
Nonmyeloabl
eng
Biology of Biol Blood 9600628 2003
321122634.xlsx

Apr
Apr
Feb
Oct
Jan
Jan
Nov
Jan
Nov
Jan
Nov
Dec
Nov
Oct
Oct
Oct
Oct
Oct
Nov
Oct
Nov
Jun
May
Jun
Dec
Jun
Mar
Feb
Dec
Aug
Oct
Jun
Sep
Oct
Oct
Oct
Nov
Jul
Jun
Apr
Aug
Sep
Apr
Feb
Mar
Feb
Mar
Jan
Jun
Nov
Sep
Sep
Sep
Aug
Aug
Jul
Jul

17

12
37
91
76
12
37
19
37
90 Suppl
37
181
36
56
18
19
23
84
36
36
36
113
63
13
26
11
45
35
35
11
80
25
24
5
45
14
18
18
34
104
22
25
9
34
18
10
89
10
25
63
72
103
110
10
28
88
32
32
32
9
9

4
8
2
10
1
2
6
2
1
11
12
2
10
5
28
11
8
10
7
4
4
3
5
6
7
11
6
2
5
8
10
5
6
9
5
5
8
10
14
2
2
4
3
4
2
3
2
3
1
12
4
6
9
9
6
4
4
7
7

438-53
803-4
285-6
799-805
1-30
155-63
289-300
135-41
ECR22
45-50
704-8
1097-101
275-81
1215-7
586-90
7032-42
722-7
683-9
867-72
565-74
220-7
1191-6
358-63
273-6
448-54
964-70
1089-93
549-56
149-60
453-7
453-7
1117-9
395-402
1175-80
522-6
552-7
518-24
721-7
3028-37
2816-25
95-7
123-9
299-303
181-92
246-58
145-53
195-203
87-90
204-11
18-25
4674-80
179-83
463-8
738-42
1044-52
543-8
433-6
411-5
472-81
453-9

Print
Print
Internet
Print
Print
Print
Print
Print
Internet
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Internet
Print
Print
Print
Print
Print
Print
Print
Print
Internet
Print
Print
Print
Print
Print

David I MaMarks, DI; Adult BMT click

U here
T Konuma Konuma, T; Ooi, J; Takclick here
Thorsten ZZenz, T; Glatting, G; click here
AleksandraHoowiecka,
Katedra i Kclick here
Theresa H Hahn, T; Wa
Roswell Paclick here
J Dahlke Dahlke, J; Departmentclick here
Allison BlaiBlair, A; G Bristol Ins click here
J M TalanoTalano, JM;Departmentclick here
Wolfgang ABethge, WA;
Medical Ceclick here
A A OyekunOyekunle, A
Departmentclick here
Hiroshi IgaIgaki, H; Departmentclick here
M Y ShapirShapira, MY
Departmentclick here
Dietger Ni Niederwiese
Departmentclick here
Takehiko MMori, T; ShDivision of click here
Zorana GruGrubic, Z; National Reclick here
K Scott Ba Baker, KS; Pediatric click here
Andreas DiDickhut, A;Departmentclick here
G Massenke
Massenkeil,Departmentclick here
M Yanada Yanada, M;Departmentclick here
A A KassimKassim, AA;
Division of click here
Dong HwanKim, DH; SDepartmentclick here
Brian M Al Alexander, Departmentclick here
Jing-Ying QQiu, JY; ZhInstitute o click here
Huan ChenChen, H; Lu
Institute o click here
Eric DeconDeconinck,Hematologyclick here
Kelly K Sa Sawczyn, KK
The Childreclick here
F Neuman Neumann, Department
F;
click here
T Hamaki Hamaki, T; Departmentclick here
Kenneth CoCornetta, KDepartmentclick here
Tatsuyuki KKai, T; KimHematologyclick here
Wei Han Han, W; Lu,Institute o click here
Qi-fa Liu Liu, QF; SuDepartmentclick here
Gero Masse
Massenkeil,Departmentclick here
Claudio AnAnnaloro, CBone Marrow
click here
T S ShamsShamsi, TS;
Departmentclick here
Tomomi ToToubai, T; Departmentclick here
Daorong LiLiu, D; TamMicrobiologclick here
M Eapen Eapen, M; S
Gtatistica click here
Mathilde HHunault, M;Hematologyclick here
Michael G Kiehl, MG; Clinic for click here
C La MorgiLa Morgia, Neurology U
click here
F Al-QurashAl-Qurashi,Section of click here
N Sato
Sato, N; FuDivision of click here
Thomas KliKlingebiel, Klinik fr click here
Ifeyinwa O Osunkwo, I;Departmentclick here
click here
Andrea CaCamera, A;Hematology,
Anna NordlNordlander,Center for click here
Huan ChenChen, H; RInstitute o click here
A Bishara Bishara, A;Tissue Typiclick here
Matteo DellPorta, MD; Section of click here
Maha El-ZiEl-Zimaity, Departmentclick here
Guillermo JRuiz-ArgeCentro de click here
Irit Avivi Avivi, I; R Departmentclick here
Natascha DDbert, N; Departmentclick here
Katarina L Le Blanc, Center for click here
N Bunin Bunin, N; The Childreclick here
P Mazza Mazza, P; P
Struttura Cclick here
K DawczynDawczynski,
1Department
click here
Kristine D Doney, K; Fred Hutchclick here
Celia Gros Grosskreutz
Bone Marroclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

18

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

19

12857560
12830736
12791654
12774060
12763142
12748665
12745275
12745266
12691137
12652465
12634724
12617870
12617869
12611068
12513721
12495909
12476283
12462025
12454748
12446423
12439699
12437658
12430885
12368958
12221672
12201469
12171713
12133439
12100139
12100136
12096391
12094473
12046256
12030109
12014810
11960336
11924922
11880704
11876962
11849234
11841456
11801465
11798883
11736947
11722994
11721425
11721423
11718088
11704796
11699202
11602415
11564090
11545420
11477437
11454889
11442503
11401086
11391721
11342452
11279633

Chimerism The
s role ofeng
Haematolog
Haematolog
0417435 2003
8504688 2003
Hematopoiet
To review teng
Seminars i Semin Onco
http://www.sci-hub.io/10.1182/blood-2003-02-0482
HLA-matched
A hematopoi
eng
Blood
Blood
7603509 2003
http://www.sci-hub.io/10.1038/sj.bmt.1704059
SuccessfulWe report teng
Bone marroBone Marro8702459 2003
IntravenousAllogeneic eng
ExperimentExp Hemat0402313 2003
http://www.sci-hub.io/10.1038/sj.bmt.1704031
HaploidentiThis is a eng
Bone marroBone Marro8702459 2003
Allogeneic Numerous eng
st
Haematolog
Haematolog
0417435 2003
Non-myeloablative cond
eng
Haematolog
Haematolog
0417435 2003
http://www.sci-hub.io/10.1080/1042819021000040242
AutologousAutologouseng
Leukemia Leuk Lymp9007422 2003
http://www.sci-hub.io/10.1053/bbmt.2003.50004
Reduced-int
A group of eng
Biology of Biol Blood 9600628 2003
http://www.sci-hub.io/10.1038/sj.bmt.1703859
Reduced int
23 patientseng
Bone marroBone Marro8702459 2003
AutologousThe prognos
eng
Best practi Best Pract 1011206592002
Stem cell t Less than 4eng
Best practi Best Pract 1011206592002
DLI or secoWe analyzed
eng
Annals of Ann Hemat9107334 2002
[Significan The purpose
chi
Zhongguo sh
Zhongguo S
1010844242002
Combination of imatinieng
Haematolog
Haematolog
0417435 2002
http://www.sci-hub.io/10.1038/sj.bmt.1703737
BasiliximabBasiliximabeng
Bone marroBone Marro8702459 2002
[Outcome of
Because ofjpn
[Rinsho ke Rinsho Ket2984782R 2002
http://www.sci-hub.io/10.1038/sj.leu.2402712
Nonmyeloabl
The feasibieng
Leukemia Leukemia 8704895 2002
Acute lympThis is a c eng
Hematology
Hematolog1008900992002
http://www.sci-hub.io/10.1038/sj.bmt.1703735
The graft-vWe studiedeng
Bone marroBone Marro8702459 2002
Double-chim
The small neng
British jou Br J Haema0372544 2002
Allogeneic We have use
eng
Internation Int J Hemat9111627 2002
http://www.sci-hub.io/10.1038/sj.bmt.1703678
Tyrosine kiEight patie eng
Bone marroBone Marro8702459 2002
http://www.sci-hub.io/10.1002/ajh.10166
A successfu
A 26-year-oeng
American j Am J Hema7610369 2002
TransplantaTransplantaeng
TransfusionTransfus A 1010956532002
http://www.sci-hub.io/10.1080/146532401317070880
Allogeneic The effect eng
CytotherapCytotherap1008953092001
16210490R2002
[A clinical To investig chi
Zhonghua n
Zhonghua N
A clinical We performe
eng
British jou Br J Haema0372544 2002
Impact of sWe evaluate
eng
British jou Br J Haema0372544 2002
[PeripheralUsing a nonspa
Gaceta md
Gac Med M0010333
Immunophen
Acute lymph
eng
Hematology/
Hematol On8709473 2002
[TreatmentDuring the cze
Casopis lkCas Lek C 0004743 2002
http://www.sci-hub.io/10.1089/108497802753773775
MyeloablatiStem cell t eng
Cancer bioCancer Bio9605408 2002
AutologousFor patienteng
Biology of Biol Blood 9600628 2002
http://www.sci-hub.io/10.1038/sj.leu.2402423
Less intensThe objectieng
Leukemia Leukemia 8704895 2002
http://www.sci-hub.io/10.1053/beha.2001.0173
Allogeneic This chapteeng
Best practi Best Pract 1011206592001
AutologousAutologouseng
Current opiCurr Opin 9007265 2002
8212398 2000
[TreatmentTo evaluatechi
Zhonghua xZhonghua X
Clinical va In this stu eng
British jou Br J Haema0372544 2002
Single-centSeventy pereng
British jou Br J Haema0372544 2002
0417435 2002
Standard ve
To analyze eng
Haematolog
Haematolog
[Unrelated To evaluatechi
Zhonghua yZhonghua Y
7511141 2001
Treatment o
Acute leukaeng
British jou Br J Haema0372544 2001
Non-myeloab
This articl eng
Hematology
Hematolog1008900992001
8212398 1999
[Comparison
To comparechi
Zhonghua xZhonghua X
[AllogeneicTo evaluatechi
Zhonghua xZhonghua X
8212398 1999
[Clinical e To evaluatechi
Zhonghua xZhonghua X
8212398 2001
http://www.sci-hub.io/10.1038/sj.bmt.1703211
Subcutaneou
Reports of eng
Bone marroBone Marro8702459 2001
http://www.sci-hub.io/10.3109/10428190109097686
Features ofThe featureeng
Leukemia Leuk Lymp9007422 2001
Comparative
This study eng
Haematolog
Haematolog
0417435 2001
IntravenousThis study eng
British jou Br J Haema0372544 2001
Atypical re Typical eareng
Clinical & Clin Exper 1008965312001
http://www.sci-hub.io/10.1038/sj.bmt.1703000
A compariso
The detectieng
Bone marroBone Marro8702459 2001
No disadvan
We evaluate
eng
Journal of J Clin Onco8309333 2001
Patient cyt We evaluate
eng
British jou Br J Haema0372544 2001
Anti-thymocTo reduce teng
Annals of Ann Hemat9107334 2001
http://www.sci-hub.io/10.1002/ajh.1109
Early onsetPneumocysti
eng
American j Am J Hema7610369 2001
PreconditioChildhood T
eng
Blood
Blood
7603509 2001
http://www.sci-hub.io/10.1002/ajh.1051
Results of Using nonmy
eng
American j Am J Hema7610369 2001
321122634.xlsx

Jul
May
Sep
Jun
May
May
May
May
Jan
Mar
Mar
Dec
Dec
Dec
Dec
Dec
Oct
Dec
Dec
Dec
Aug
Oct
Sep
Aug
Apr
Jul
Jul
2002 MayApr
Mar
Apr
Apr
Dec
Mar
Feb
Mar
Feb
Jan
Mar
Dec
Aug
Aug
Aug
Oct
Jun
Oct
Sep
Aug
Apr
Jul
Jun
Apr
Jul
May
Apr

20

88
7
19
2
102
6
31
11
31
5
31
10
88
5
88
5
44
1
9
3
31
5
15
4
15
4
81 Suppl 2
10
6
87
12
30
12
43
10
16
12
30
11
119
3
76 Suppl 1
30
7
71
1
27
1
3
4
41
4
118
1
118
1
138
3
16
2
141
4
17
2
8
4
16
4
14
4
14
2
21
2
116
3
116
2
87
1
81
5
115
3
20
20
22
28
42
86
114
29
27
19
113
80
67
97
66

8
8
8
7
1-2
10
4
4
8
14
4
4
3
10
4

801-10
118-32
2021-30
1057-9
428-34
889-95
555-60
484-6
9-14
157-61
339-45
675-93
653-74
S34-5
557-60
ECR38
899-903
904-10
2423-8
162-92
761-8
773-6
376-9
453-7
37-40
3-12
253-60
256-8
140-3
128-31
235-9
245-99, v
122-6
151-63
213-20
581-6
793-805
152-9
74-6
686-94
483-90
52-8
263-7
622-9
375-91
427-30
420-3
399-402
709-11
145-50
1087-94
944-50
225-9
809-15
3406-14
1060-71
209-15
206-9
3218-25
241-4

Internet
Print
Print
Print
Print
Print
Internet
Internet
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print

Manuel BarBarrios, M;Hematologyclick here

Hollie DeviDevine, H; Stem Cell click here
Michael B Maris, MB; Fred Hutchclick here
J Ishikawa Ishikawa, JDepartmentclick here
Avichai Sh Shimoni, A;Departmentclick here
S Singhal Singhal, S;Royal Marsclick here
Rodrigo MaMartino, R;Division of click here
Nicola GkGkbuget, N; Hoelzer,click here
Gerlinde E Egerer, G; Departmentclick here
David GmGmez-Alma
Hospital U click here
G Massenke
Massenkeil,Departmentclick here
Albert GraGraena Bat
Haematology
click here
I Avivi
Avivi, I; R Departmentclick here
H T GreinixGreinix, HTDepartmentclick here
Hai-Lin WaWang, HL; Department
S
click here
Stefan Fru Fruehauf, SDepartmentclick here
G Massenke
Massenkeil,Dept. of In click here
Satoru TakTakada, S; Departmentclick here
R Arnold Arnold, R; Medizinischclick here
Dieter HoelHoelzer, D University click here
M RembergRemberger,Departmentclick here
Marcos DeDe Lima, M;
Departmentclick here
Guillermo JRuiz-ArgelCentro de H
click here
W Y Au
Au, WY; Li Departmentclick here
Taeko UehUehara, T; Second Depa
click here
Andrew S DDaly, AS; Departmentclick here
G Grman Grman, G;Ankara Univ
click here
Lanping XuXu, L; HuanPeking Univclick here
Jun Ooi Ooi, J; Ise Departmentclick here
Yoshinobu Kanda, Y; TStem Cell Tclick here
David GmGmez-Alma
Servicio declick here
Roger S RiRiley, RS; Departmentclick here
M Doubek Doubek, M;Interni he click here
Inga Buch Buchmann,Department
I
click here
Daniel WeiWeisdorf, DUniversity click here
R F SchlenSchlenk, RF
Departmentclick here
D I Marks Marks, DI Adult Boneclick here
Norbert-Cl Gorin, NC Departmentclick here
D Zou
Zou, D; Han
Institute click here
Joaquin SSnchez, J;Haematolog
click here
F A Al-Kas Al-Kasim, FDivision of click here
Andrea Men
Mengarelli,Dipartimentclick here
H Huang Huang, H; Departmentclick here
R Pawson Pawson, R;Royal Freeclick here
R F Storb Storb, RF; Fred Hutchclick here
M Wang Wang, M; HInstitute click here
B Wu
Wu, B; SunNanfang Hos
click here
W Huang Huang, W; Hematologyclick here
A Okano Okano, A; S
Second Dep
click here
G J Ruiz-ArRuiz-ArgelCentro de click here
M G VicentVicent, MGDepartmentclick here
U S SchuleSchuler, U Departmentclick here
G W BylsmBylsma, GW;
Departmentclick here
A H ElmaagElmaagacli,Departmentclick here
U M SaarinSaarinen-PiHospital fo click here
N Krger Krger, N; Bone Marroclick here
N Krger Krger, N; Departmentclick here
T Saito
Saito, T; S Hematopoiet
click here
D P Dialyn Dialynas, DDepartmentclick here
G J Ruiz-ArRuiz-ArgeCentro de click here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

21

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

22

11274765
11253611
11253604
11240249
11216708
11201154
11189510
11189505
11167752
11069031
11063870
11049022
11025598
11022631
11008023
10983327
10967573
10962806
10929024
10918401
10811452
10784626
10713638
10706067
10637248
10602428
10573141
10483141
10414236
10414235
10411969
10338041
10334542
10218846
10084254
10078628
10071037
9916648
9916643
9894715
9877263
9834212
9783800
9780338
9753343
9725058
9721472
9635716
9619912
9578306
9577641
9575394
9570681
9535034
9489653
9487372
9486493
9457826
9384474
9375751

Low-intensiMatched unr
eng
ExperimentExp Hemat0402313 2001
Allogeneic Acute lymph
eng
Hematology/
Hematol On8709473 2001
AutologousAutologouseng
Hematology/
Hematol On8709473 2001
Total body This study eng
Internation Int J Radia 7603616 2001
Smooth mus
We report aeng
Journal of J Pediatr 9505928 2001
[Nonmyeloab
We describe
jpn
[Rinsho ke Rinsho Ket2984782R 2000
[Outcome of
To evaluatechi
Zhonghua xZhonghua X
8212398 1998
[Changes of
To investig chi
Zhonghua xZhonghua X
8212398 1998
Is there a During a 13eng
British jou Br J Haema0372544 2000
A phase I/I Busulfan haeng
Leukemia Leukemia 8704895 2000
Adoptive imPatients wheng
ExperimentExp Hemat0402313 2000
New approa
The optimizeng
Seminars i Semin Onc0420432 2000
0417435 2000
Hematopoiet
There is oneng
Haematolog
Haematolog
The Cape To
To determineng
South AfricS Afr Med 0404520 2000
Second alloSecond alloeng
ExperimentExp Hemat0402313 2000
[A second allogeneic trus
Terapevtiche
Ter Arkh 2984818R 2000
http://www.sci-hub.io/10.1038/sj.bmt.1702510
Myelodyspla
The incideneng
Bone marroBone Marro8702459 2000
[AllogeneicFifty three spa
Medicina Medicina (B0204271 2000
Incidence oIn the ligh eng
British jou Br J Haema0372544 2000
http://www.sci-hub.io/10.1038/sj.bmt.1702451
Outcome ofOne hundred
eng
Bone marroBone Marro8702459 2000
http://www.sci-hub.io/10.3109/10428190009060323
AutologousWe conducte
eng
Leukemia Leuk Lymp9007422 2000
Partially m To extend aeng
Journal of J Clin Onco8309333 2000
http://www.sci-hub.io/10.1038/sj.bmt.1702186
Constrictiv We describe
eng
Bone marroBone Marro8702459 2000
TransplantaEarly studi eng
ExperimentExp Hemat0402313 2000
Comparison
Preparativeeng
Journal of J Clin Onco8309333 2000
Long-term fBetween 198
eng
Leukemia Leukemia 8704895 1999
The role ofGraft versueng
Leukemia rLeuk Res 7706787 1999
[Infantile We report ojpn
[Rinsho ke Rinsho Ket2984782R 1999
Allogeneic Between 199
eng
HematologiHematol On8307268 1998
Allogeneic Unmodifiedeng
HematologiHematol On8307268 1998
Quantity anMultivariat eng
Croatian me
Croat Med 9424324 1999
http://www.sci-hub.io/10.1038/sj.bmt.1701744
Long-term o
We studiedeng
Bone marroBone Marro8702459 1999
Improved ou
To eliminateng
Journal of J Clin Onco8309333 1999
http://www.sci-hub.io/10.1038/sj.bmt.1701636
Early PCR-n
Acute lymph
eng
Bone marroBone Marro8702459 1999
http://www.sci-hub.io/10.1038/sj.bmt.1701576
AutologousWe have rec
eng
Bone marroBone Marro8702459 1999
Total body To investig eng
Internation Int J Radia 7603616 1999
Ex vivo depPreventing eng
TransplantaTransplanta0132144 1999
The number
AlloPBSC-Teng
Bone marroBone Marro8702459 1998
Allogeneic From Septem
eng
Bone marroBone Marro8702459 1998
http://www.sci-hub.io/10.1038/sj.bmt.1701521
FLAG-idarub
We describe
eng
Bone marroBone Marro8702459 1998
http://www.sci-hub.io/10.1038/sj.bmt.1701498
Intensified We investigeng
Bone marroBone Marro8702459 1998
7603509 1998
Minimal resThe efficaceng
Blood
Blood
The role ofPost-transpeng
Leukemia rLeuk Res 7706787 1998
http://www.sci-hub.io/10.1056/NEJM199810223391702
Treatment o
In this stu eng
The New En
N Engl J M0255562 1998
Low incidenUsing unreleng
TransplantaTransplanta0132144 1998
[Peripheral blood stemjpn
Gan to kagGan To Ka 7810034 1998
[Allogenic Most childrcze
Casopis lkCas Lek C 0004743 1998
Interstitia To identify eng
Internation Int J Radia 7603616 1998
Engraftment
Mitoxantroneng
Leukemia rLeuk Res 7706787 1998
http://www.sci-hub.io/10.1038/sj.bmt.1701152
Leukemia-frBetween Apr
eng
Bone marroBone Marro8702459 1998
[An analysiA 19-year-ojpn
[Rinsho ke Rinsho Ket2984782R 1998
Risk factor Three hundr
eng
Clinical tra Clin Transp8710240 1998
http://www.sci-hub.io/10.3109/10428199709058601
High-dose tThe use of eng
Leukemia Leuk Lymp9007422 1997
http://www.sci-hub.io/10.1038/sj.bmt.1701120
T cell-depl To increaseeng
Bone marroBone Marro8702459 1998
http://www.sci-hub.io/10.1038/sj.bmt.1701034
A second un
A second bo
eng
Bone marroBone Marro8702459 1998
Total-body In order to eng
StrahlentheStrahlenth 8603469 1998
http://www.sci-hub.io/10.1038/sj.bmt.1701067
TransplantaTwenty-seve
eng
Bone marroBone Marro8702459 1998
High-energy
Bone marrow
eng
Internation Int J Radia 7603616 1998
http://www.sci-hub.io/10.1038/sj.bmt.1700964
Allogeneic Attempts toeng
Bone marroBone Marro8702459 1997
Non-transfePrevious steng
British jou Br J Haema0372544 1997
321122634.xlsx

Mar
Feb
Feb
Mar
Feb
Dec
Aug
Aug
Dec
Nov
Nov
Oct
Oct
Aug
Sep
Aug
Jun
Jul
Jun
May
Mar
Feb
Jan
Dec
Oct
Jul
Dec
Dec
Sep
May
May
Apr
Feb
Feb
Feb
Dec
Dec
Dec
Dec
Dec
Nov
Oct
Sep
Aug
Jun
Jun
Mar
Apr
Mar
Apr
Dec
Mar
Feb
Feb
Jan
Jan
Nov
Nov

23

29
3
15
1
15
1
49
4
23
2
41
12
19
8
19
8
111
4
14
11
28
11
27
5
85
10
90
8
28
9
72
7
26
3
60
2
109
4
26
1
38
1-2
18
9
25
5
28
2
18
2
13
12
23
10
40
7
16
4
16
4
40
3
23
9
17
5
23
7
23
3
43
3
67
4
22 Suppl 4
22 Suppl 4
22
12
22
11
92
11
22
11
339
17
66
5
25
10
137
12
41
3
22
3
21
7
39
3
12
2
26 Suppl 1
21
5
21
3
174
2
21
1
40
2
20
9
99
2

362-70
97-120
121-43
1071-7
139-41
1277-80
422-4
402-4
1130-7
1954-9
1225-31
540-59
1060-7
804-11
1096-104
68-9
321-6
179-87
743-50
17-22
103-11
1856-66
571-3
119-27
340-7
2053-8
947-52
574-80
163-8
155-62
404-8
875-9
1545-50
695-6
235-41
497-503
620-6
S92-5
S77-9
1137-43
1029-33
4072-9
991-5
1186-93
620-5
1613-7
363-7
651-7
209-13
673-8
185-92
84-92
61-7
431-40
291-3
92-104
43-9
391-6
731-5
337-43

Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print

A Nagler Nagler, A; Departmentclick here

T G Martin Martin, TG;Departmentclick here
T G Martin Martin, TG;Departmentclick here
S Bieri
Bieri, S; HeOncology Inclick here
B Brichard Brichard, BDepartmentclick here
Y Abe
Abe, Y; HarDepartmentclick here
M Han
Han, M; Fen
Institute click here
Y Ma
Ma, Y; QiaoSecond Afficlick here
O RingdnRingdn, O;Centre for click here
E OlavarriaOlavarria, Departmentclick here
A Nagler Nagler, A; Departmentclick here
D Hoelzer Hoelzer, D J.W. Goethe
click here
click here
E GranadoGranados, Haematolog
P Roux
Roux, P; No
University click here
A Nagler Nagler, A; The Departclick here
E E ObukhObukhova, EE; Melkovclick here
S Park
Park, S; BrServices d'click here
G KusminsKusminsky,Unidad de click here
R Wsch Wsch, R; Departmentclick here
A SchattenSchattenber
Departmentclick here
K Muroi Muroi, K; SDepartmentclick here
K T GodderGodder, KT;Division o click here
J Cavet Cavet, J; LDepartmentclick here
Y Reisner Reisner, Y;Departmentclick here
S M DaviesDavies, SM;
Internation click here
D S SnyderSnyder, DS;Departmentclick here
F Rosales Rosales, F;Departmentclick here
D HasegawHasegawa,Departmentclick here
W Y Au
Au, WY; Li University click here
O Arslan Arslan, O; University click here
click here
D Rogulj Rogulj, D; Dubrava Uni
S Singhal Singhal, S;Leukaemiaclick here
F Aversa Aversa, F; T
BMT Program
click here
S D'Sa
D'Sa, S; VeDepartmentclick here
R M LemoliLemoli, RM;
Institute o click here
R Corv Corv, R; PServizio di click here
N NovitzkyNovitzky, The Univerclick here
W Knopisk
Knopiska-Departmentclick here
click here
T Masszi Masszi, T; Bone Marrow
M Deane Deane, M; D
Kepartmentclick here
N Krger Krger, N; Bone Marroclick here
C J KnechtlKnechtli, CDepartmentclick here
A Nagler Nagler, A; Departmentclick here
F Aversa Aversa, F; T
Departmentclick here
O RingdnRingdn, O;Departmentclick here
R KuribaraKuribara, RDept. of Meclick here
J Star
Star, J; K II. dtsk click here
C Aristei Aristei, C; Institute o click here
A Nagler Nagler, A; Departmentclick here
H T GreinixGreinix, HTDepartmentclick here
Y NakazawNakazawa,Departmentclick here
S Carlens Carlens, S Departmentclick here
C Carlo-SteCarlo-Stell Departmentclick here
D A MavrouMavroudis,Bone Marrow
click here
N Basara Basara, N; Clinic of click here
Y BelkacmBelkacmi,Departmentclick here
O RingdnRingdn, O;Bone Marroclick here
J Bradley Bradley, J; Departmentclick here
E DeconincDeconinck,Departmentclick here
S J Bradle Bradley, SJDepartmentclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

24

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

25

9332336
9269758
9311276
9293448
9240635
9262989
9193746
9250828
9136960
9116308
9130690
9052912
9066585
8971372
9166553
9039221
9009260
8874214
8857949
8879623
8879614
8879608
8790160
8864452
8823261
8832004
8652385
9364037
8758293
8722368
8641927
8701254
8646739
8833405
12118567
9054052
8673054
8750280
8545791
9372031
7654044
7557234
7780158
8525207
7655393
7537528
7773226
7745299
7762256
8083714
7940125
8059784
7946543
7933569
7524888
8167351
8054919
8197754
8019445
8011550

TransplantaThis trial eng

British jou Br J Haema0372544 1997
7603509 1997
Marrow tranTransplantaeng
Blood
Blood
[Double autA 24-year-ojpn
[Rinsho ke Rinsho Ket2984782R 1997
http://www.sci-hub.io/10.1055/s-2008-1043947
Good engraIn vivo modeng
Klinische Pa
Klin Padiat 0326144
Low energyTo evaluateeng
Internation Int J Radia 7603616 1997
Incidence oGraft versueng
Hematology
Hematol Ce9613253 1997
http://www.sci-hub.io/10.1038/sj.bmt.1700797
Toxicity as Seventy-threng
Bone marroBone Marro8702459 1997
http://www.sci-hub.io/10.3109/10428199709039045
melphalan,Causes of teng
Leukemia Leuk Lymp9007422 1997
Donor lymph
Four childr eng
British jou Br J Haema0372544 1997
7603509 1997
Detection oThirty-six eng
Blood
Blood
Studies of The aim was
eng
Leukemia Leukemia 8704895 1997
http://www.sci-hub.io/10.1038/sj.bmt.1700680
Second alloTo assess teng
Bone marroBone Marro8702459 1997
Factors inf In the pres eng
Anticancer Anticancer 8102988
Melphalan M
a elphalan e
hng
Bone marroBone Marro8702459 1996
Allogeneic We evaluate
eng
The cancerCancer J S9513568
QuantitativAcute oral eng
European jo
Eur J Canc9214373 1996
Comparison of haematol
eng
Leukemia rLeuk Res 7706787
Growth pattWe examined
eng
Blood
Blood
7603509 1996
In vivo mobWe have pre
eng
British jou Br J Haema0372544 1996
Prognostic Between Jun
eng
Bone marroBone Marro8702459 1996
Bone marrow
We report 1eng
Bone marroBone Marro8702459 1996
A pilot stu In this pil eng
Bone marroBone Marro8702459 1996
Unrelated dAllogeneic eng
British jou Br J Haema0372544 1996
Molecular sWe investigeng
Bone marroBone Marro8702459 1996
Total body Radiation-ieng
Internation Int J Radia 7603616 1996
Melphalan-tForty-four eng
Bone marroBone Marro8702459 1996
A compariso
We retrospe
eng
British jou Br J Haema0372544 1996
Late pulmon
The pulmona
eng
European jo
Eur J Med 9517857 1996
The combina
To explore eng
Chinese me
Chin Med J7513795 1996
Central nerFour hundre
eng
Bone marroBone Marro8702459 1996
Cataractoge
To evaluateeng
Internation Int J Radia 7603616 1996
[SuccessfulA 45-year-oger
SchweizeriSchweiz M 0404401 1996
t(1;5)(q23; The t(1;5)( eng
Cancer genCancer Gen
7909240 1996
http://www.sci-hub.io/10.3109/10428199609052431
Allogenic t Six patient eng
Leukemia Leuk Lymp9007422 1996
Interstitia To assess teng
Internation Int J Radia 7603616 1996
[Bone marro
The effect rus
Terapevtiche
Ter Arkh 2984818R 1996
Partially m Patients wheng
Bone marroBone Marro8702459 1996
Severe migr
CAMPATH-1G
eng
Bone marroBone Marro8702459 1995
Is veno-occIn order to eng
StrahlentheStrahlenth 8603469 1995
Donor leuko
Treatment o
eng
Current opiCurr Opin 9430802 1995
Deficit of The immunol
eng
Anticancer Anticancer 8102988
[RestoratioThe early srus
Gematologii
Gematol Tr8301796
Sustained lA retrospeceng
Blood
Blood
7603509 1995
[Allogenic We have tre
spa
Revista mRev Med Ch
0404312 1995
SuccessfulA 23-year-oeng
Bone marroBone Marro8702459 1995
PhiladelphiTen patienteng
British jou Br J Haema0372544 1995
High-dose Conditionineng
Bone marroBone Marro8702459 1995
[Good respo
This 35-yeajpn
Kansenshog
Kansensho0236671 1995
AutologousFrom April eng
Wiener med
W ien Med 8708475 1995
Etoposide, To determineng
Journal of J Clin Onco8309333 1994
[The signif The triage ger
StrahlentheStrahlenth 8603469 1994
Adult acuteTo analyze eng
The AmericAm J Med 0267200 1994
Allogeneic Bone marrow
eng
Journal of J Paediatr 9005421 1994
[Bone marro
We report ajpn
[Rinsho ke Rinsho Ket2984782R 1994
http://www.sci-hub.io/10.3109/10428199409049679
High dose bWe retrospe
eng
Leukemia Leuk Lymp9007422 1994
A randomize
Between Oct
eng
Blood
Blood
7603509 1994
Acute tumor
We report aeng
Bone marroBone Marro8702459 1994
[Innsbruck 87 patientsger
Wiener kli Wien Klin 21620870R1994
Retinal micThree patieeng
Bone marroBone Marro8702459 1994
Allogeneic We report 1eng
British jou Br J Haema0372544 1994
321122634.xlsx

Sep
Aug
Aug
1997 Jul-A
Jul
Jun
Jun
May
Apr
Apr
Mar
Mar
1997 JanDec
1996 NovNov
1996 NovOct
Oct
Sep
Sep
Sep
Sep
Aug
Aug
Jul
Jun
Apr
Apr
Apr
Apr
Mar
Mar
Feb
Jan
Jan
Dec
Dec
Nov
1995 Jul-A
1995 Jul-A
Jun
May
Apr
Mar
Feb
Feb
Sep
Sep
Aug
Aug
Aug
Jul
May
May
Jan
Jan

26

98
3
90
4
38
8
209
4
38
4
39
3
19
11
25
5-6
97
1
89
7
11 Suppl 1
19
5
17
1B
18
6
2
6
32B
6
20
11-12
88
8
95
1
18
3
18
3
18
3
94
3
18
2
36
1
18
1
93
3
1
7
109
4
17
4
35
1
126
9
87
1
20
5-6
34
1
68
12
17
1
16
6
171
12
2
6
15
4
40
4
85
12
123
5
15
4
89
3
15
2
69
2
145
2-3
12
9
170
9
97
2
30
4
35
8
14
3-4
83
9
13
5
106
7
13
1
86
1

760-6
1410-4
689-95
178-85
697-703
133-6
1061-4
565-72
165-8
2602-9
S32-4
461-6
589-99
1049-55
330-4
381-7
993-6
3137-46
127-30
591-6
533-40
495-9
574-8
397-403
77-82
119-23
637-45
343-8
304-7
637-41
53-60
362-5
4-6
471-4
71-7
8-10
49-53
843-5
694-7
423-30
1553-60
3-10
3754-61
605-11
637-8
535-8
321-3
213-7
61-4
1923-30
538-44
176-84
319-23
801-3
279-83
2723-30
659-60
201-7
101-4
62-9

Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print

A Bacigalu Bacigalupo,Divisione Eclick here

J Sierra Sierra, J; Fred Hutchclick here
M Tabata Tabata, M; Division of click here
G Baersch Baersch, G;Klinik und click here
D Cowen Cowen, D; D
Tepartmentclick here
O Ilhan
Ilhan, O; A Departmentclick here
M Kumar Kumar, M; D
S epartmentclick here
P HjiyiannaHjiyiannakiDepartmentclick here
A Atra
Atra, A; Mi Departmentclick here
J Radich Radich, J; Clinical R click here
S Giralt
Giralt, S; Departmentclick here
K Kishi
Kishi, K; T First Deparclick here
H T Hassa Hassan, HT;
Bone Marroclick here
S Singhal Singhal, S;Leukaemiaclick here
C Aristei Aristei, C; Institute o click here
C Tardieu Tardieu, C;Laboratoireclick here
M StockschStockschlder, M; Hasclick here
Y Yan
Yan, Y; SalDepartmentclick here
A M Carell Carella, AMHaematolog
click here
A ZapateroZapatero, ARadiation Oclick here
C M Rubin Rubin, CM;Departmentclick here
N Vey
Vey, N; De Institut Pa click here
A Oakhill Oakhill, A Royal Hospit
click here
A H ElmaagElmaagacliDepartmentclick here
Y BelkacmBelkacmi,Departmentclick here
J Mehta Mehta, J; PLeukaemiaclick
U here
O RingdnRingdn, O;Departmentclick here
T Beinert Beinert, T; Universitt click here
C Wang Wang, C; Qi
Departmentclick here
S Singhal Singhal, S;Leukaemiaclick here
Y BelkacmBelkacmi,Departmentclick here
R BurkhardBurkhard, Abteilung f click here
F Barriga Barriga, F; Departmentclick here
C Rozman Rozman, C;Postgraduat
click here
M OzsahinOzsahin, M;Departmentclick here
S I Moisee Moiseev, SI; Ganapievclick here
K Godder Godder, K; University click here
G Varadi Varadi, G; Departmentclick here
Y BelkacmBelkacmi,Departmentclick here
F van Rhe van Rhee, Adult Leuk click here
H R DiamoDiamond, HBone Marrow
click here
L S Liubim Liubimova, LS; Glask click here
R Haas
Haas, R; WDepartmentclick here
F Barriga Barriga, F; Departament
click here
A Maruta Maruta, A; Departmentclick here
click here
A M Carell Carella, AMHaematolog
K van Besivan BesienUniversity click here
S Mizuno Mizuno, S; Bone Marrow
click here
D Nemet Nemet, D; L
Departmentclick here
S A Giralt Giralt, SA; Departmentclick here
A Hartman Hartmann, K
Alinik fr click here
H M KantarKantarjian Departmentclick here
M R VowelVowels, MRDepartmentclick here
N Uike
Uike, N; SuDepartmentclick here
M A RosentRosenthal,Bone Marrow
click here
O RingdnRingdn, O;Division of click here
J NomdedNomdedu,Departmentclick here
D NachbauNachbaur, A
Dbteilung f click here
J M O'Rior O'Riordan,Departmentclick here
D J WeisdoWeisdorf, Bone Marroclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

27

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

28

7912099
Haemopoieti
A retrospeceng
British jou Br J Haema0372544 1994
8136750
SuccessfulWe report aeng
Bone marroBone Marro8702459 1993
8136742
Allogeneic In a retros eng
Bone marroBone Marro8702459 1993
7918033
Allogeneic We have inv
eng
British jou Br J Haema0372544 1993
8298563
AutologousThe resultseng
Bone marroBone Marro8702459 1993
8124215 http://www.sci-hub.io/10.3109/10428199309067935
Long-term rAutologouseng
Leukemia Leuk Lymp9007422 1993
8410124
Adult acuteIn a prospeeng
Journal of J Clin Onco8309333 1993
8275030
AutologousBetween Dec
eng
Bone marroBone Marro8702459 1993
8251416
B-cell lympA 25-year-oeng
British jou Br J Haema0372544 1993
8241982
Incidence of
Eighty-eigheng
Bone marroBone Marro8702459 1993
7688833
[Clinical apPeripheral jpn
Rinsho byorRinsho Byo2984781R 1993
8469555
PostextractThis reporteng
Oral surgerOral Surg 0376406 1993
8431710
Use of cytoWe report teng
Bone marroBone Marro8702459 1993
8420066
Interleukin Despite int eng
TransplantaTransplanta0132144 1993
8124252
Allogeneic Eighty conseng
Bone marroBone Marro8702459 1993
7687533
[High dose Four patienchi
Zhonghua zh
Zhonghua Z
7910681 1993
1471304
[GranulocytWe have eva
dan
Ugeskrift f Ugeskr Lae0141730 1992
1464004
Effect of r The presenc
eng
Bone marroBone Marro8702459 1992
1515886
SuccessfulWe report seng
Bone marroBone Marro8702459 1992
1515876
AutologousIn order to eng
Bone marroBone Marro8702459 1992
1353774
Detection oChemotherap
eng
InternationaInt J Radiat8809243 1992
1617318
Total body From June eng
1
Bone marroBone Marro8702459 1992
1411640
TeniposideThe epipodo
eng
Seminars i Semin Onc0420432 1992
1429095
Immunophen
In the prec eng
Internation Int J Radia 7603616 1992
1835411
In vitro an The radiobieng
Blood
Blood
7603509 1991
1758050
[The analysThis reportjpn
[Rinsho ke Rinsho Ket2984782R 1991
1919638
Busulfan, cSixteen pateng
Journal of J Clin Onco8309333 1991
1720339
Granulocyte
Colony-stimeng
Bone marroBone Marro8702459 1991
1942524
[Bone marro
We reported
jpn
[Rinsho ke Rinsho Ket2984782R 1991
1853457
[AutologousThe authors
dan
Ugeskrift f Ugeskr Lae0141730 1991
1873592
Treatment o
Between Feb
eng
Bone marroBone Marro8702459 1991
1656487
Interstitia The records
eng
Radiation Radiat Med8412264
2067082
[AutologousAutologousjpn
[Rinsho ke Rinsho Ket2984782R 1991
2065543
Bone marrow
The bone ma
eng
Chinese me
Chin Med J7513795 1991
2009375
7603509 1991
AutologousWe report teng
Blood
Blood
2023563
AutologousTen patienteng
Medical and
Med Pediat7506654 1991
1934921
Blood produ
Three group
eng
Clinical an Clin Lab H 7907061 1991
1890865
AutologousFourty succeng
Leukemia Leukemia 8704895 1991
1878676
VP16 and TBI as condi
eng
Bone marroBone Marro8702459 1991
1855278
Unaltered pThe pharmac
eng
Cancer cheCancer Ch 7806519 1991
1855083
AutologousThis study eng
Bone marroBone Marro8702459 1991
1812998
Autoantibod
Various auteng
AutoimmuniAutoimmuni8900070 1991
2291992
AutologousWe report heng
Bone marroBone Marro8702459 1990
2254105
FractionateFrom March
eng
Internation Int J Radia 7603616 1990
2089854
[Whole body
Preliminarypor
Acta mdi Acta Med P7906803
2280616
[Bone marro
Fifteen bonspa
Medicina cliMed Clin (B0376377 1990
2202462
Bone marrow
The efficaceng
Bone marroBone Marro8702459 1990
2350628
Thyroid dysThyroid funeng
Bone marroBone Marro8702459 1990
2185338
Allogeneic The prognos
eng
Journal of J Clin Onco8309333 1990
2107007
Bone marrow
Leukemic re
eng
Bone marroBone Marro8702459 1990
2247642
Technique,Twenty-fiveeng
Radiotherap
Radiother 8407192 1990
2247634
Clinical an Eighty-nineeng
Radiotherap
Radiother 8407192 1990
2103142
Bone marroLeukemic re
eng
Clinical tra Clin Transp8812419 1990
2627618
New conditiBone marrow
eng
Bone marroBone Marro8702459 1989
2676139
Central nerThis study eng
Cancer
Cancer
0374236 1989
2687967
[Fractionat Two differeita
La RadioloRadiol Med0177625 1989
2511115
0417435
Allogeneic Thirty pati eng
Haematolog
Haematolog
2659120
Busulfan and cyclophoeng
Bone marroBone Marro8702459 1989
2650787
Prevention In the pres eng
Bone marroBone Marro8702459 1989
2650786
AnthracycliFactors whieng
Bone marroBone Marro8702459 1989
321122634.xlsx

Jan
Dec
Dec
Dec
Nov
Nov
Oct
Oct
Sep
Sep
Apr
Mar
Jan
Jan
Jan
Dec
Nov
Jul
Jul
Jul
May
Apr
Dec
Nov
Oct
Sep
Aug
Jun
Jun
1991 MayApr
Apr
Apr

Nov
Nov
1990 NovSep
Jul
May
May
Feb

Dec
Nov
Oct
1989 SepMay
Mar
Mar

29

86
1
12
6
12
6
85
4
12
5
11
5-6
11
10
12
4
85
1
12
3
41
4
75
3
11
1
55
1
12 Suppl 3
15
1
154
52
10
5
10
1
10
1
62
1
9
5
19
2 Suppl 6
24
4
78
11
32
11
9
10
8
3
32
8
153
25
7
6
9
3
32
4
104
4
77
7
19
3
13
2
5 Suppl 1
7 Suppl 2
28
3
7 Suppl 3
11
1
6
5
19
5
3
6
95
9
6
1
5
5
8
5
5
2
18 Suppl 1
18 Suppl 1
4 Suppl 4
64
78
74
4
4
4

9
4
5
3
2
2

70-5
Print
659-60
Print
583-9
Print
706-13
Print
517-23
Print
419-25
Print
1990-2001Print
315-21
Print
99-102
Print
233-6
Print
384-9
Print
391-6
Print
43-50
Print
61-6
Print
S2-6
Print
47-51
Print
3754-7
Print
425-30
Print
93-5
Print
33-8
Print
33-43
Print
343-7
Print
59-64
Print
705-12
Print
2945-55 Print
1433-8
Print
1880-8
Print
191-5
Print
851-4
Print
1785-9
Print
453-9
Print
118-21
Print
381-5
Print
267-76
Print
1593-8
Print
160-4
Print
107-14
Print
42-5
Print
131
Print
214-6
Print
28-30
Print
7-12
Print
301-7
Print
1151-4
Print
337-40
Print
324-8
Print
9-16
Print
335-40
Print
809-12
Print
83-9
Print
146-50
Print
118-20
Print
165-73
Print
15-7
Print
1796-804 Print
367-72
Print
455-61
Print
331-3
Print
167-71
Print
163-6
Print

L Pierelli Pierelli, L Servizio di click here

A SamuelsSamuelsson
Departmentclick here
L Sutton Sutton, L; Group d'Et click here
A von Buelvon BueltziUnit de T click here
J Sierra Sierra, J; Postgraduat
click here
click here
G Lamberten
Lambertengh
Centro Trapi
D Fire
Fire, D; L Service d'Hclick here
K Doney Doney, K; BDivision of click here
M S TrimblTrimble, MS
Departmentclick here
M D HamoHamon, MD;
Departmentclick here
M Harada Harada, M 1st Departm
click here
A Barasch Barasch, A;Departmentclick here
C WeymanWeyman, C;
University oclick here
D J WeisdoWeisdorf, Departmentclick here
T De WitteDe Witte, TDepartmentclick here
G Q Wu Wu, GQ Departmentclick here
P Jessen Jessen, P; Arhus Amtsclick here
E A ChalmeChalmers, D
E epartmentclick here
N Giri
Giri, N; V Departmentclick here
J Baro
Baro, J; Ri Hospital Unclick here
A A van Lo van Loon, TNO Medical
click here
B Labar Labar, B; BDepartmentclick here
P SonnevelSonneveld,University click here
F M UckunUckun, FM;Departmentclick here
F M UckunUckun, FM;Section of click here
M YoshimuYoshimura,Center for click here
G L PhillipsPhillips, G Leukemia/Bclick here
B Sallerfor Sallerfors, Departmentclick here
M Yazaki Yazaki, M; Departmentclick here
B Nielsen Nielsen, B;Arhus Amtsclick here
K Doney Doney, K; FDivision of click here
K Kurisu Kurisu, K; Departmentclick here
T Kataoka Kataoka, TFirst Deparclick here
D C Cao Cao, DC; TBone Marroclick here
P J Carey Carey, PJ; University click here
R Gonzale Gonzales-CPittsburgh click here
O P Smith Smith, OP;Departmentclick here
G Santini Santini, G; Division of click here
click here
R SchwerdtSchwerdtfeg
UKRV Charl
G EhningerEhninger, GMedizinischclick here
P ColleselliColleselli, Clinica Pediclick here
click here
M SanmarcSanmarco,Laboratoire
M
A M Stopp Stoppa, AM;
Marrow Tran
click here
C AltschuleAltschuler, Institut J. click here
L Jorge
Jorge, L; PDepartament
click here
C Richard Richard, C;Servicio declick here
W G WoodWoods, WG;
Bone Marroclick here
E KatsanisKatsanis, EDepartmentclick here
X TroussarTroussard, Bone Marroclick here
B Bostrom Bostrom, BDepartmentclick here
A Urgesi Urgesi, A; Departmentclick here
J HoogenhHoogenhout
Departmentclick here
click here
C Tiley
Tiley, C; P Leukemia U
R J Jones Jones, RJ; Johns Hopkclick here
G Ganem Ganem, G;Department
K
click here
R Corv Corv, R; Frassoni, F;click here
E AngeluccAngelucci, E; Polchi, Pclick here
A PorcelliniPorcellini, A; Manna, click here
J RaemaekRaemaekers,
Departmentclick here
N Van der Van der LelDepartmentclick here
321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

30

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
321122634.xlsx

31

2564220
Failure of CD18 antibo
eng
TransplantaTransplanta0132144
2498186
0417435
Results of Thirty-one eng
Haematolog
Haematolog
2480284
Improved sIn most ceneng
Folia haema
Folia Haema
0374615
2480281
Allogeneic In the time eng
Folia haema
Folia Haema
0374615
2480280
Bone marrow
This reporteng
Folia haema
Folia Haema
0374615
3056556
Acute esoph
Gastrointeseng
Bone marroBone Marro8702459
3071346
Recombinan
Bone marrow
eng
Behring InsBehring Ins0367532
3042040
IntravasculRenal diseaeng
Blood
Blood
7603509
3048497
Safe applicTwo conditieng
Bone marroBone Marro8702459
3276822
Allogeneic Twenty-seve
eng
Journal of J Clin Onco8309333
2898752
[AutograftsThirty-nine fre
Nouvelle reNouv Rev F7909092
3332169
Pericardial We report teng
Bone marroBone Marro8702459
3332160
Bone marrow transplan
eng
Bone marroBone Marro8702459
3296209
Cytosine arDuring A-AL
eng
Seminars i Semin Onc0420432
3524657
AutologousThirty-thre eng
British jou Br J Haema0372544
3516715
TransplantaAutologouseng
ExperimentExp Hemat0402313
3510496
Cotton-woolRetinal cot eng
TransplantaTransplanta0132144
3896727 http://www.sci-hub.io/10.1055/s-2008-1069033
[AllogeneicAllogeneic ger
Deutsche m
Dtsch Med 0006723
6386505
Secondary Secondary
m
eng
m
ExperimentExp Hemat0402313
4909449
Bone marrow
Allogeneic eng
British medBr Med J 0372673

321122634.xlsx

1989

Mar
1989 Jan-

1989
1989
1989
1988
1988
1988
1988
1988
1988
1987
1987
1987
1986
1986
1986
1985
1984
1970

Sep
Aug
Aug
Jul
Feb
Aug
Jun
Jun
Jul
May
Jan
Sep
Sep
Apr

32

47
74
116
116
116
3
72
3
6
30
2
2
14
63
14
41
110
12
2

3
1
3-4
3-4
3-4
5
83
2
4
2
1-2
2
1
2 Suppl 1
3
4
1
39
8
5702

472-4
67-70
421-5
403-8
397-402
513-6
313-9
451-5
349-56
227-31
69-73
213-6
85-9
67-72
457-70
278-86
60-2
1488-93
660-6
131-6

Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print
Print

D Baume Baume, D; Service

K
d'Hclick here
G Meloni Meloni, G; De Fabritiisclick here
H J Kolb Kolb, HJ; BMedizinischclick here
W Wiktor-JWiktor-JedrHaemopoiet
click here
H J Kolb Kolb, HJ; BMedizinischclick here
D Memoli Memoli, D; Vincent T. click here
H Link
Link, H; Fr Interdiscip click here
E C Guina Guinan, EC;
Departmentclick here
H P Davis Davis, HP; Departmentclick here
J P VernanVernant, JPService d'hclick here
S CastaignCastaigne, Unit d'Hm
click here
P A Veys Veys, PA; Departmentclick here
J Graham- Graham-Pole
Departmentclick here
P StryckmaStryckmans, P; De Witt
click here
J Y Cahn Cahn, JY; Herve, P; Flclick here
P M SondeSondel, PM; Hank, JA;click here
M OechslinOechslin, M; Thiel, G click here
N Schmitz Schmitz, N; Kayser, click here
H J Deeg Deeg, HJ; Sanders, J;click here
G Math Math, G; Amiel, JL; click here

321122634.xlsx

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here
click here

33

journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal
journal

321122634.xlsx

id
author
title
booktitle year
volume
pages
number
abstract
hematopoietic8cell
fludarabine plus 2 Gy TBI
Baron2015 Baron, FrdNon-myeloablative
Journal allogeneic
of
2015
4 transplantation following
1 BackgroundF
Bunin2003
Cattaneo20Cattaneo, CA randomizeJournal of
2011
66 21402145
9 Background
Chalandon Chalandon,Randomized
Blood
2015
125 37113719
24 In this stu
Chen2013
Chevallier2014
Choi2014 Choi, InpyoDonor-DerivBiology of
2014
20 696704
5 The doses o
Colleselli1991
DeStefano2De Stefano,Treatment oHaematolog
2011
96 245248
The standar
Fiere1993
Gupta2011 Gupta, T anCyclophosph
Hematology/
2011
4 1729
1 Cyclophosph
Huang2001
Hunault2004
Hunault2007
J.2010
J., Pidala Allogeneic hBlood
2010
116
21 Background:
Jessen1992
Kanda2014Kanda, Juny
Reduced-intBiology of
2014
20 257263
2 We present
Katsanis1990
Kebriaei2013
Kornblit201Kornblit, B FludarabineBiology of
2013
19 13401347
9 The risks a
List2000 List, A F a A randomized
Bone Marro
2000
25 283291
3 The purpose
Liu2013
Liu, Dai Ho Substitutio Internation
2013
98 708715
6 The modified busulfan-cyclopho
Nagler1998
Pidala2011
Rosenthal1994
Seftel2014 Seftel, M D Superiority Blood
2014
124
21 Introductio
Shouval201Shouval, R A machine lHaematolog
2014
99 164
164 Background:
Ulm2014 Ulm, UniverOral SessioBone Marrow
2014
49 S6S88
Introductio
Woods1990

url
doi
keywords author2
title3
journal
year4
volume5 pages6
http://www.jhoonline.org/content/8/1/4
10.1186/s1 allo-hct,atg,graft-versus-leukemia effects,gvhd,non-myeloablative conditioning,tbi,tli
Bunin, N anRandomized
Bone marrow
2003 32
543548
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/912/CN-00798912/frame.html
10.1093/jacEchinocandins,IFIs,Invasive fungal infections
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/770/CN-01083770/frame.html
10.1182/bl Adolescent,Adult[checkword],Antineoplastic Combined Chemotherapy Protocols [ad,BCR ABL prote
Chen, J and[Efficacies Zhonghua Y
2013 93
583587
Chevallier, Results from
Haematolog
2014 99
14861491
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/253/CN-00984253/frame.html
10.1016/j.b Donor natural killer cell infusion,Human leukocyte antigen-haploidentical hematopoiet
Colleselli, Autologous Bone Marro
1991 7 Suppl 3 2830
http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L71702182
adult,allogeneic hematopoietic stem cell transplantation,anticoagulant agent,anticoagulant therapy,a
Fire, D an Adult acuteJournal of c
1993 11
19902001
http://dx.doi.org/10.5144/1658-3876.2011.17
http://dx.d acute graft versus host disease/co [Complication]
Huang, W a[Clinical ef Zhonghua X
2001 22
399402
Hunault, MaBetter outc Blood
2004 104
30283037
Hunault, MaOutcome ofHaematolog
2007 92
16231630
http://abstracts.hema *acute lymphoblastic leukemia,*cell transplantation,*hematology,*hematopoietic cell,*meta analysis,*
Jessen, P a[GranulocytUgeskrift fo
1992 154
37543757
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/904/CN-00978904/frame.html
10.1016/j.b Alemtuzumab,Haploidentical,Matched-related,Matched-unrelated,Reduced-intensity
Katsanis, EThyroid dysfBone Marro
1990 5
335340
Kebriaei, P IntravenousBone marrow
2013 48
2631
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/404/CN-00918404/frame.html
10.1016/j.b Body irradiation,Fludarabine/low dose total,HLA-matched related,Hematopoietic cell,Nonmyeloablati
http://www.ncbi.nlm.nih.gov/pubmed/10673700
10.1038/sj. Adult,Anti-Inflammatory Agents, Non-Steroidal/therapeuti,Antineoplastic Combined Chemotherapy P
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/081/CN-00961081/frame.html
10.1007/s1 Conditioning regimen,Cyclophosphamide,Fludarabine,Pneumonia
Nagler, A a The role of Leukemia r
1998 22
991995
Pidala, Jos Allogeneic hThe Cochran
2011
CD008818
Rosenthal, High dose bLeuk Lymp
1994 14
279283
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/703/CN-01049703/frame.html
American,Philadelphia chromosome negative cell,acute lymphoblastic leukemia,adult,cancer center,
http://ovidsp.ovid.c
HLA system,acute granulocytic leukemia,acute leukemia,acute lymphoblastic leukemia,adult,algorith
http://www.nature.com/doifinder/10.1038/bmt.2014.43
10.1038/bmHLA system,acute granulocytic leukemia,acute leukemia,acute lymphoblastic leukemia,adult,algorith
Woods, W G
Bone marrow
Bone marrow
1990 6
916

number7 edition
abstract8 url9
doi10
annote
keywords1 editor
publisher
nditioning,tbi,tli
6
2003/09/04Conditioninhttp://www.ncbi.nlm.nih.gov/pubmed/12953124
10.1038/sj. Bunin, N ApAdolescent,Adult,Bone Marrow Transplantation,Bone M

py Protocols [ad,BCR ABL protein/ec [Endogenous Compound],Benzamides [administration & dosage] [therapeutic,Disease-Free Surviv
http://www.ncbi.nlm.nih.gov/pubmed/23663336
8
2013/05/15OBJECTIVE:
Chen, Jia W*Hematopoietic Stem Cell Transplantation,Adolescent,A
9
2014/06/22We prospectively evalu10.3324/ha1592-8721 *CHematopoietic Stem Cell Transplantation,Adenine Nuc
tical hematopoiet
1991/01/01This study http://www.ncbi.nlm.nih.gov/pubmed/1855083
Colleselli, *Bone Marrow Transplantation,Adolescent,Adult,Child,C
nt agent,anticoagulant therapy,antivitamin K,apixaban,bleeding,bleeding disorder,blood clotting factor,blood clotting factor 10a inhibitor,b
10
1993/10/01PURPOSE:http://www.ncbi.nlm.nih.gov/pubmed/8410124
In
Fiere, D Le Adolescent,Adult,Antineoplastic Agents,Antineoplastic

http://www.ncbi.nlm.nih.gov/pubmed/11718088
8
2001/11/23 OBJECTIVE:
Huang, W Zh
*Hematopoietic Stem Cell Transplantation,Adolescent,A
10
2004/07/17Various transplantatio 10.1182/bl Hunault, Ma*Bone Marrow Transplantation,Adolescent,Adult,Antine
12
2007/12/07BACKGROUND AND OBJECTI
10.3324/ha1592-8721 A
Hutologous bone marrow transplantation,Lymphoblasti
matopoietic cell,*meta analysis,*remission,*society,*systematic review,Embase,Medline,adult,consolidation chemotherapy,consultation,d
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med3&NEWS=N&AN=14
52
1992/12/21We have eva
Jessen, P N*Bone Marrow Transplantation/ae [Adverse Effects],*G
duced-intensity
5
1990/05/01Thyroid funhttp://www.ncbi.nlm.nih.gov/pubmed/2350628
Katsanis, EAdolescent,Adult,Anemia, Aplastic/surgery,Bone Marro
1
2012/06/27We investighttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4346146&tool=pmcentrez&rend
10.1038/bmt
1476-5365 A
Kdult,Age Factors,Alkylating,Alkylating/administration &
matopoietic cell,Nonmyeloablative conditioning,Transplantation randomized,Trial
stic Combined Chemotherapy Protocols/the,Behavior Therapy,Bone Marrow Transplantation/*adverse effects,Combined Modality Thera

11
1998/10/23Post-transplant leukemic relapse rNagler, A FiAdolescent,Adult,Antineoplastic Combined Chemother
10
BACKGROUND:
http://www.ncbi.nlm.nih.gov/pubmed/21975786
10.1002/14651858.CDAdult,HematPidala, Jos John Wiley
3-4
1994/07/01We retrospectively rev10.3109/10Rosenthal, *Bone Marrow Transplantation,Acute Disease,Administ
ic leukemia,adult,cancer center,cell transplantation,central nervous system,central nervous system disease,chemotherapy,death,diagno
hoblastic leukemia,adult,algorithm,allogeneic hematopoietic stem cell transplantation,area under the curve,artificial intelligence,blood,bo
hoblastic leukemia,adult,algorithm,allogeneic hematopoietic stem cell transplantation,area under the curve,artificial intelligence,blood,bo
1
1990/07/01The efficachttp://www.ncbi.nlm.nih.gov/pubmed/2202462
Woods, W G
Adolescent,Adult,Bone Marrow Transplantation,Bone M

month

address

e Marrow Transplantation,Bone Marrow Transplantation/methods/mortality,Bone Marrow Transplantation: methods,Bone Marrow Transp

[therapeutic,Disease-Free Survival,Female[checkword],Humans[checkword],Imatinib Mesylate,Male[checkword],Middle Aged[checkwor

Cell Transplantation,Adolescent,Adult,Benzamides/*therapeutic use,Female,Humans,Male,Middle Aged,Philadelphia Chromosome,Pipe
Cell Transplantation,Adenine Nucleotides/therapeutic use,Adult,Aged,Antilymphocyte Serum/therapeutic use,Arabinonucleosides/therap

antation,Adolescent,Adult,Child,Child, Preschool,Cyclophosphamide/therapeutic use,Dose-Response Relationship, Drug,Female,Huma

ood clotting factor 10a inhibitor,body weight,brain,brain cancer,cancer patient,central nervous system,central venous catheter,chemothe
eoplastic Agents,Antineoplastic Agents: adverse effects,Antineoplastic Agents: therapeutic use,Bone Marrow Transplantation,Combined

Cell Transplantation,Adolescent,Adult,Female,Humans,Male,Precursor Cell Lymphoblastic Leukemia-Lymphoma/mor,Transplantation, A

antation,Adolescent,Adult,Antineoplastic Agents/administration & dosage,Antineoplastic Combined Chemotherapy Protocols/*ad,Aspara
ow transplantation,Lymphoblastic acute leukemia,Lymphoblastic lymphoma
ion chemotherapy,consultation,data base,disease free survival,donor,forest,hazard ratio,human,induction chemotherapy,information pro
antation/ae [Adverse Effects],*Granulocyte-Macrophage Colony-Stimulating Factor/,*Lymphoma/th [Therapy],*Precursor Cell Lymphobla

mia, Aplastic/surgery,Bone Marrow Transplantation/*adverse effects,Child,Child, Preschool,Combined Modality Therapy,Female,Follow-U

ylating,Alkylating/administration &,Alkylating: administration & dosage,Alkylating: adverse effects,Alkylating: therapeutic use,Antineoplas

effects,Combined Modality Therapy,Dose-Response Relationship, Drug,Double-Blind Method,Evaluation Studies as Topic,Female,Graft

eoplastic Combined Chemotherapy Protocols,Bone Marrow Transplantation,Busulfan,Child,Child, Preschool,Cyclophosphamide,Diseas

oct
Chichester, UK
antation,Acute Disease,Administration, Oral,Adolescent,Adult,Antineoplastic Combined Chemotherapy Protocols/*ad,Busulfan/administ
ase,chemotherapy,death,diagnosis,disease free survival,donor,hematocrit,hematology,hematopoietic cell,human,leukocyte count,morta
rve,artificial intelligence,blood,bone marrow,computer,conditioning,coping behavior,data analysis,data mining,decision tree,diagnosis,do
rve,artificial intelligence,blood,bone marrow,computer,conditioning,data analysis,data mining,decision tree,diagnosis,donor,hematopoiet
e Marrow Transplantation,Bone Marrow Transplantation: adverse effects,Bone Marrow Transplantation: methods,Child,Clinical Trials as

: methods,Bone Marrow Transplantation: mortality,Busulfan,Busulfan/therapeutic use,Busulfan: therapeutic use,Child,Cord Blood Stem

eckword],Middle Aged[checkword],Philadelphia Chromosome,Philadelphia chromosome positive cell,Piperazines [administration & dosa

,Philadelphia Chromosome,Piperazines/*therapeutic use,Precursor Cell Lymphoblastic Leukemia-Lymphoma/*ge,Pyrimidines/*therapeu
c use,Arabinonucleosides/therapeutic use,Busulfan/therapeutic use,Drug Administration Schedule,Female,Graft Survival/immunology,Hu

elationship, Drug,Female,Humans,Italy,Male,Precursor Cell Lymphoblastic Leukemia-Lymphoma/dru,Prognosis,Transplantation, Autolo

ntral venous catheter,chemotherapy,cohort analysis,confidence interval,consensus,continuous infusion,dabigatran etexilate,diagnosis,d
arrow Transplantation,Combined Modality Therapy,Female,Humans,Male,Middle Aged,Precursor Cell Lymphoblastic Leukemia-Lympho

mphoma/mor,Transplantation, Autologous,Treatment Outcome

motherapy Protocols/*ad,Asparaginase/administration & dosage,Combined Modality Therapy,Daunorubicin/administration & dosage/*an

on chemotherapy,information processing,long term survival,model,mortality,myeloablative conditioning,nonmyeloablative conditioning,on

rapy],*Precursor Cell Lymphoblastic Leukemia-Lymphoma/th,Adolescent,Adult,Bone Marrow,Bone Marrow Transplantation,Cyclophosp

odality Therapy,Female,Follow-Up Studies,Humans,Infant,Leukemia, Myeloid, Acute/surgery,Male,Precursor Cell Lymphoblastic Leukem

ng: therapeutic use,Antineoplastic Agents,Busulfan,Busulfan/administration & dosage/adverse effects/t,Busulfan: administration & dosa

n Studies as Topic,Female,Graft vs Host Disease/etiology/prevention & contro,HLA Antigens,Hematologic Neoplasms/therapy,Humans,In

chool,Cyclophosphamide,Disease-Free Survival,Evaluation Studies as Topic,Female,Humans,Infant,Leukemia, Myeloid, Acute,Male,Mid

Protocols/*ad,Busulfan/administration & dosage/adverse effects,Combined Modality Therapy,Cyclophosphamide/administration & dosag

ell,human,leukocyte count,mortality,myeloablative conditioning,pH,patient,phosphorus 32,randomized controlled trial,recipient,relapse,re
mining,decision tree,diagnosis,donor,hematology,hematopoietic cell,high risk population,human,leukemia,logistic regression analysis,mac
ee,diagnosis,donor,hematopoietic cell,high risk population,human,learning algorithm,machine learning,model,morbidity,mortality,patient,
methods,Child,Clinical Trials as Topic,Combined Modality Therapy,Cyclophosphamide,Cyclophosphamide: therapeutic use,Cytarabine,C

utic use,Child,Cord Blood Stem Cell Transplantation,Cord Blood Stem Cell Transplantation/methods/morta,Cord Blood Stem Cell Trans

perazines [administration & dosage] [therapeutic,Precursor Cell Lymphoblastic Leukemia-Lymphoma [dr,Protein Kinase Inhibitors [admin
homa/*ge,Pyrimidines/*therapeutic use,Transplantation Conditioning,Transplantation, Homologous,Treatment Outcome,Young Adult
ale,Graft Survival/immunology,Humans,Leukemia, Biphenotypic, Acute/immunology/mortality,Leukemia, Myeloid, Acute/immunology/mor

rognosis,Transplantation, Autologous,Vincristine/*therapeutic use,Whole-Body Irradiation

dabigatran etexilate,diagnosis,digestive system cancer,female,fondaparinux,hematology,heparin,human,kidney,lenalidomide,leukemia,l
ymphoblastic Leukemia-Lymphoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma: dr,Precursor Cell Lymphoblastic Leukemia-Lym

icin/administration & dosage/*analogs & de,Humans,Interferon-alpha/administration & dosage,Middle Aged,Philadelphia Chromosome,P

onmyeloablative conditioning,oncology,overall survival,patient,randomization,randomized controlled trial,randomized controlled trial (top

ow Transplantation,Cyclophosphamide,Erythrocyte Transfusion,Female,Hodgkin Disease/bl [Blood],Hodgkin Disease/et [Etiology],Hodg

ursor Cell Lymphoblastic Leukemia-Lymphoma/sur,Thyroid Diseases/*etiology,Thyroid Gland/drug effects/radiation effects

Busulfan: administration & dosage,Busulfan: adverse effects,Busulfan: therapeutic use,Combination,Combination/adverse effects,Com

c Neoplasms/therapy,Humans,Infection/chemically induced,Male,Middle Aged,Nuclear Family,Pentoxifylline/administration & dosage/*a

ukemia, Myeloid, Acute,Male,Middle Aged,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thiotepa,Time Factors,Transplantation C

phamide/administration & dosage/adverse e,Dose-Response Relationship, Drug,Drug Administration Schedule,Female,Granulocyte Co

ontrolled trial,recipient,relapse,remission,society,survival,therapy,transplantation,treatment failure,univariate analysis,unrelated donors
,logistic regression analysis,machine learning,model,morbidity,mortality,overall survival,patient,prediction,procedures,receiver operating
model,morbidity,mortality,patient,patient coding,prediction,receiver operating characteristic,recipient,reduced intensity conditioning,regist
de: therapeutic use,Cytarabine,Cytarabine: administration & dosage,Cytarabine: therapeutic use,Female,Graft Survival,Graft vs Host Di

orta,Cord Blood Stem Cell Transplantation: methods,Cord Blood Stem Cell Transplantation: mortality,Female,Hematopoietic Stem Cell T

Protein Kinase Inhibitors [administration & dosage,Pyrimidines [administration & dosage] [therapeutic,Stem Cell Transplantation,Treatm
tment Outcome,Young Adult
Myeloid, Acute/immunology/mortality/path,Leukemia-Lymphoma/immunology/mortality/pathology/*,Male,Middle Aged,Myeloablative Ago

n,kidney,lenalidomide,leukemia,long term care,low molecular weight heparin,lung cancer,lymphatic leukemia,lymphoma,malignant neopl

ell Lymphoblastic Leukemia-Lymphoma: im,Precursor Cell Lymphoblastic Leukemia-Lymphoma: th,Prospective Studies,Remission Indu

ged,Philadelphia Chromosome,Precursor Cell Lymphoblastic Leukemia-Lymphoma/gen,Prognosis,Remission Induction,Transplantation

,randomized controlled trial (topic),relapse,risk,sensitivity analysis,sibling,study design,survival,therapy,toxicity,unrelated donors,whole b

dgkin Disease/et [Etiology],Hodgkin Disease/th [Therapy],Hospitalization,Humans,Lymphoma,Lymphoma,Non-Hodgkin/bl [Blood],Lymph

s/radiation effects
ombination/adverse effects,Combination: adverse effects,Drug Therapy,Female,Follow-Up Studies,Graft vs Host Disease,Graft vs Host D

lline/administration & dosage/*analogs &,Placebos/administration & dosage,Recurrence,Survival Rate,Time Factors,Tissue Donors,Tran

,Time Factors,Transplantation Conditioning,Transplantation, Autologous,administration & dosage,adverse effects,methods,mortality,ther

chedule,Female,Granulocyte Colony-Stimulating Factor/adverse effe,Hematopoietic Stem Cell Transplantation,Hodgkin Disease/*drug t

ate analysis,unrelated donors
n,procedures,receiver operating characteristic,recipient,register,risk,risk assessment,statistical analysis,statistical significance,stratificati
ced intensity conditioning,register,relapse,risk,risk assessment,transplantation,univariate analysis,validity,weight
e,Graft Survival,Graft vs Host Disease,Graft vs Host Disease: prevention & control,Humans,Male,Precursor Cell Lymphoblastic Leukem

male,Hematopoietic Stem Cell Transplantation,Hematopoietic Stem Cell Transplantation/methods/mo,Hematopoietic Stem Cell Transpl

tem Cell Transplantation,Treatment Outcome,Young Adult[checkword],acute lymphoblastic leukemia/dt [Drug Therapy],acute lymphobla

,Middle Aged,Myeloablative Agonists/*therapeutic use,Myelodysplastic Syndromes/immunology/mortality/pat,Precursor Cell Lymphobla

emia,lymphoma,malignant neoplastic disease,meta analysis,metastasis,multiple myeloma,neoplasm,occlusive cerebrovascular disease,

spective Studies,Remission Induction,Survival Analysis,Treatment Outcome

ission Induction,Transplantation, Homologous,Treatment Outcome,Vincristine/administration & dosage

oxicity,unrelated donors,whole body radiation

a,Non-Hodgkin/bl [Blood],Lymphoma,Non-Hodgkin/et [Etiology],Lymphoma,Non-Hodgkin/th [Therapy],Lymphoma/bl [Blood],Lymphoma

vs Host Disease,Graft vs Host Disease/epidemiology/etiology/preven,Graft vs Host Disease: epidemiology,Graft vs Host Disease: etiolo

Time Factors,Tissue Donors,Transplantation, Homologous/adverse effects,Whole-Body Irradiation,derivatives/pharmacokinetics/toxicity

se effects,methods,mortality,therapeutic use,therapy

ntation,Hodgkin Disease/*drug therapy/*therapy,Humans,Leukemia, Myeloid/*drug therapy/*therapy,Lymphoma, Non-Hodgkin/*drug the

statistical significance,stratification,survival,transplantation,tree,validity

sor Cell Lymphoblastic Leukemia-Lymphoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma: dr,Precursor Cell Lymphoblastic Leu

ematopoietic Stem Cell Transplantation: methods,Hematopoietic Stem Cell Transplantation: mortality,Homologous,Humans,Infant,Male

[Drug Therapy],acute lymphoblastic leukemia/th [Therapy],adult,allogeneic stem cell transplantation,article,autologous stem cell transpl

y/pat,Precursor Cell Lymphoblastic,Recurrence,Survival Analysis,Transplantation Conditioning/*methods,Transplantation, Homologous

clusive cerebrovascular disease,outpatient,ovary,pancreas,partial thromboplastin time,patient,pentasaccharide,plasma,population,preva

ymphoma/bl [Blood],Lymphoma/et [Etiology],Male,Precursor Cell Lymphoblastic Leukemia-Lymphoma/bl,Precursor Cell Lymphoblastic

ogy,Graft vs Host Disease: etiology,Graft vs Host Disease: prevention & control,Hematopoietic Stem Cell Transplantation,Hematopoietic

atives/pharmacokinetics/toxicity

mphoma, Non-Hodgkin/*drug therapy/*therapy,Male,Middle Aged,Precursor Cell Lymphoblastic Leukemia-Lymphoma/*dr,Retrospective S

ecursor Cell Lymphoblastic Leukemia-Lymphoma: ra,Precursor Cell Lymphoblastic Leukemia-Lymphoma: su,Whole-Body Irradiation

omologous,Humans,Infant,Male,Peripheral Blood Stem Cell Transplantation,Peripheral Blood Stem Cell Transplantation/methods,Perip

cle,autologous stem cell transplantation,cancer chemotherapy,cancer survival,controlled study,cyclophosphamide/cb [Drug Combination

s,Transplantation, Homologous

haride,plasma,population,prevalence,prophylaxis,purpura,randomized controlled trial,risk,risk factor,rivaroxaban,society,solid,stomach,s

bl,Precursor Cell Lymphoblastic Leukemia-Lymphoma/et,Regeneration,Transplantation,Transplantation,Autologous

ll Transplantation,Hematopoietic Stem Cell Transplantation/adverse ef,Hematopoietic Stem Cell Transplantation: adverse e,Homologou

a-Lymphoma/*dr,Retrospective Studies,Stomatitis/chemically induced,Survival Analysis

ma: su,Whole-Body Irradiation

l Transplantation/methods,Peripheral Blood Stem Cell Transplantation: method,Peripheral Blood Stem Cell Transplantation: mortal,Prec

sphamide/cb [Drug Combination],cyclophosphamide/ct [Clinical Trial],cyclophosphamide/dt [Drug Therapy],cyclophosphamide/iv [Intrav

roxaban,society,solid,stomach,surgery,thalidomide,therapy,thrombin inhibitor,thrombocyte,thrombocyte count,thrombosis,vein thrombos

Autologous

antation: adverse e,Homologous,Humans,Incidence,Infusions,Intravenous,Male,Melphalan,Melphalan/adverse effects/therapeutic use,

Cell Transplantation: mortal,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma/mo

py],cyclophosphamide/iv [Intravenous Drug Administrati,cytarabine/ct [Clinical Trial],cytarabine/dt [Drug Therapy],dexamethasone/cb [D

count,thrombosis,vein thrombosis,venous thromboembolism

adverse effects/therapeutic use,Melphalan: adverse effects,Melphalan: therapeutic use,Middle Aged,Myeloablative Agonists,Myeloablati

blastic Leukemia-Lymphoma/mor,Precursor Cell Lymphoblastic Leukemia-Lymphoma: mo,Precursor Cell Lymphoblastic Leukemia-Lymp

Therapy],dexamethasone/cb [Drug Combination],dexamethasone/ct [Clinical Trial],dexamethasone/dt [Drug Therapy],dexamethasone/p

eloablative Agonists,Myeloablative Agonists/administration & dosage/adv,Myeloablative Agonists: administration & dosage,Myeloablative

ll Lymphoblastic Leukemia-Lymphoma: th,Preschool,Recurrence,Survival Analysis,Transplantation,Transplantation Conditioning,Transp

Drug Therapy],dexamethasone/po [Oral Drug Administration],doxorubicin/cb [Drug Combination],doxorubicin/ct [Clinical Trial],doxorubici

istration & dosage,Myeloablative Agonists: adverse effects,Myeloablative Agonists: therapeutic use,Precursor Cell Lymphoblastic Leuke

splantation Conditioning,Transplantation Conditioning/methods/mortality,Transplantation Conditioning: methods,Transplantation Conditi

bicin/ct [Clinical Trial],doxorubicin/dt [Drug Therapy],event free survival,female,filgrastim/ct [Clinical Trial],filgrastim/dt [Drug Therapy],filg

cursor Cell Lymphoblastic Leukemia-Lymphoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma/pre,Precursor Cell Lymphoblastic L

methods,Transplantation Conditioning: mortality,Whole-Body Irradiation

],filgrastim/dt [Drug Therapy],filgrastim/iv [Intravenous Drug Administration],filgrastim/sc [Subcutaneous Drug Administration],fluorescen

e,Precursor Cell Lymphoblastic Leukemia-Lymphoma: pr,Precursor Cell Lymphoblastic Leukemia-Lymphoma: th,Secondary Prevention,

Drug Administration],fluorescence in situ hybridization,follow up,human,imatinib/cb [Drug Combination],imatinib/ct [Clinical Trial],imatinib

homa: th,Secondary Prevention,Survival Analysis,Texas,Transplantation,Transplantation Conditioning,Transplantation Conditioning/adve

imatinib/ct [Clinical Trial],imatinib/dt [Drug Therapy],imatinib/po [Oral Drug Administration],leukocyte count,major clinical study,male,mer

ansplantation Conditioning/adverse effects,Transplantation Conditioning: adverse effects,Young Adult

nt,major clinical study,male,mercaptopurine/ct [Clinical Trial],mercaptopurine/dt [Drug Therapy],mercaptopurine/po [Oral Drug Administr

opurine/po [Oral Drug Administration],methotrexate/ct [Clinical Trial],methotrexate/dt [Drug Therapy],methotrexate/po [Oral Drug Admini

thotrexate/po [Oral Drug Administration],methotrexate/tl [Intrathecal Drug Administration],minimal residual disease,multicenter study,mu

al disease,multicenter study,multiple cycle treatment,overall survival,pegfilgrastim/ct [Clinical Trial],pegfilgrastim/dt [Drug Therapy],pegfi

lgrastim/dt [Drug Therapy],pegfilgrastim/sc [Subcutaneous Drug Administration,prednisone/ct [Clinical Trial],prednisone/dt [Drug Therap

rial],prednisone/dt [Drug Therapy],prednisone/po [Oral Drug Administration],priority journal,randomized controlled trial,recurrence free su

controlled trial,recurrence free survival,reduced intensity conditioning,reverse transcription polymerase chain reaction,vincristine/cb [Dru

hain reaction,vincristine/cb [Drug Combination],vincristine/ct [Clinical Trial],vincristine/dt [Drug Therapy],vincristine/iv [Intravenous Drug

vincristine/iv [Intravenous Drug Administration]